<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">107726</article-id>
<article-id pub-id-type="doi">10.7554/eLife.107726</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107726.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.3</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptional responses to chronic oxidative stress require cholinergic activation of G-protein-coupled receptor signaling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7243-1422</contrib-id>
<name>
<surname>Biswas</surname>
<given-names>Kasturi</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1099-5721</contrib-id>
<name>
<surname>Moore</surname>
<given-names>Caroline</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0008-8485-7138</contrib-id>
<name>
<surname>Rogers</surname>
<given-names>Hannah</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3559-7962</contrib-id>
<name>
<surname>Wani</surname>
<given-names>Khursheed A</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5340-8294</contrib-id>
<name>
<surname>Pukkila-Worley</surname>
<given-names>Read</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4660-354X</contrib-id>
<name>
<surname>Higgins</surname>
<given-names>Daniel P</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1899-8916</contrib-id>
<name>
<surname>Walker</surname>
<given-names>Amy K</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mullen</surname>
<given-names>Gregory P</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rand</surname>
<given-names>James B</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="author-notes" rid="n2">$</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8076-6668</contrib-id>
<name>
<surname>Francis</surname>
<given-names>Michael M</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<email>Michael.Francis@umassmed.edu</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Department of Neurobiology, University of Massachusetts Chan Medical School</institution></institution-wrap>, <city>Worcester</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Program in Neuroscience, University of Massachusetts Chan Medical School</institution></institution-wrap>, <city>Worcester</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School</institution></institution-wrap>, <city>Worcester</city>, <country country="US">United States</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Program in Molecular Medicine, University of Massachusetts Chan Medical School</institution></institution-wrap>, <city>Worcester</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035z6xf33</institution-id><institution>Genetic Models of Disease Research Program, Oklahoma Medical Research Foundation</institution></institution-wrap>, <city>Oklahoma City</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Kratsios</surname>
<given-names>Paschalis</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Chicago</institution>
</institution-wrap>
<city>Chicago</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Sen</surname>
<given-names>Sonia</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Tata Institute for Genetics and Society</institution>
</institution-wrap>
<city>Bangalore</city>
<country>India</country>
</aff>
</contrib>
</contrib-group>
<author-notes><fn id="n1" fn-type="present-address"><label>#</label><p>Present address: Department of Biology, Johns Hopkins University, Baltimore, MD</p></fn><fn id="n2" fn-type="present-address"><label>$</label><p>Present address: Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-08-26">
<day>26</day>
<month>08</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP107726</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-06-24">
<day>24</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-06-25">
<day>25</day>
<month>06</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.01.06.628021"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Biswas et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Biswas et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-107726-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Organisms have evolved protective strategies that are geared toward limiting cellular damage and enhancing organismal survival in the face of environmental stresses, but how these protective mechanisms are coordinated remains unclear. Here, we define a requirement for neural activity in mobilizing the antioxidant defenses of the nematode <italic>Caenorhabditis elegans</italic> both during chronic oxidative stress and prior to its onset. We show that acetylcholine-deficient mutants are particularly vulnerable to chronic oxidative stress. We find that extended oxidative stress mobilizes a broad transcriptional response which is strongly dependent on both cholinergic signaling and activation of the muscarinic G-protein acetylcholine coupled receptor (mAChR) GAR-3. Gene enrichment analysis revealed a lack of upregulation of proteasomal proteolysis machinery in both cholinergic-deficient and <italic>gar-3</italic> mAChR mutants, suggesting that muscarinic activation is critical for stress-responsive upregulation of protein degradation pathways. Further, we find that GAR-3 overexpression in cholinergic motor neurons prolongs survival during chronic oxidative stress. Our studies demonstrate neuronal modulation of antioxidant defenses through cholinergic activation of G protein-coupled receptor signaling pathways, defining new potential links between cholinergic signaling, oxidative damage, and neurodegenerative disease.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>chronic oxidative stress</kwd>
<kwd>ROS</kwd>
<kwd><italic>Caenorhabditis elegans</italic></kwd>
<kwd>transcriptomics</kwd>
<kwd>RNA-Seq</kwd>
<kwd>neurotransmitter</kwd>
<kwd>acetylcholine</kwd>
<kwd><italic>gar-3</italic></kwd>
<kwd>proteasome</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id>
<institution>National Institute of Neurological Disorders and Stroke</institution>
</institution-wrap>
</funding-source>
<award-id>R01NS064263</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/021nxhr62</institution-id>
<institution>National Science Foundation</institution>
</institution-wrap>
</funding-source>
<award-id>1755019</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/049v75w11</institution-id>
<institution>National Institute on Aging</institution>
</institution-wrap>
</funding-source>
<award-id>R01AG068670</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Typing error corrections.
Included supplementary table call-outs (ex. Table S4, S5) in the main text.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Organisms encounter a wide variety of deleterious internal and external stressors throughout their lifespan. The ability to effectively respond to these stress conditions is crucial for limiting damage and enhancing organismal survival. Transcriptional activation or repression of stress-responsive gene networks in specific cells or tissues is a key component of organismal protective strategies. For instance, adaptive transcriptional responses are important for protection from pathogen infection or exposure to exogenous chemicals and toxins (<xref ref-type="bibr" rid="c9">Cao, 2016</xref>; <xref ref-type="bibr" rid="c30">Hu et al., 2023</xref>; <xref ref-type="bibr" rid="c33">Irazoqui et al., 2010</xref>; <xref ref-type="bibr" rid="c53">Nandi &amp; Aroeti, 2023</xref>). Moreover, impaired stress responses contribute to human age-related diseases, including neurodegenerative disorders such as Alzheimer’s disease (<xref ref-type="bibr" rid="c7">Biswas et al., 2022</xref>; <xref ref-type="bibr" rid="c45">Ma et al., 2011</xref>; <xref ref-type="bibr" rid="c46">Manoharan et al., 2016</xref>). Defining gene regulatory networks that limit damage in response to stress and the mechanisms for their coordination across tissues is therefore an area of intense interest. The nervous system has recently emerged as an important nexus in coordinating systemic stress responses, such as the mitochondrial unfolded protein response (UPR<sup>mt</sup>) (<xref ref-type="bibr" rid="c3">Bar-Ziv et al., 2023</xref>; <xref ref-type="bibr" rid="c44">Liu et al., 2022</xref>). However, the extent of nervous system participation in coordinating responses to other classes of environmental stressors is not clearly defined.</p>
<p>Oxidative stress is among the most significant and damaging stresses that organisms must face. It occurs as a result of the aberrant accumulation of reactive oxygen species (ROS) and is an important aggravating factor in the pathogenesis of a variety of diseases, including cancer, diabetes, and neurodegenerative disease (<xref ref-type="bibr" rid="c5">Bhatti et al., 2022</xref>; <xref ref-type="bibr" rid="c7">Biswas et al., 2022</xref>; <xref ref-type="bibr" rid="c71">Valko et al., 2004</xref>; <xref ref-type="bibr" rid="c80">Zhang et al., 2011</xref>). During oxidative stress, excess ROS cause cellular damage by reacting with biomolecules such as proteins and lipids (<xref ref-type="bibr" rid="c2">Back et al., 2012</xref>; <xref ref-type="bibr" rid="c37">Juan et al., 2021</xref>; <xref ref-type="bibr" rid="c57">Paulsen et al., 2011</xref>; <xref ref-type="bibr" rid="c79">Yang et al., 2016</xref>). A major adverse consequence of both oxidative stress and neurodegenerative disease is an accumulation of insoluble toxic protein aggregates, which occur as a result of perturbed protein homeostasis (proteostasis) and produce further proteostasis disruptions. To protect against oxidative stress, eukaryotes activate sophisticated transcriptional responses for the upregulation of defense systems that cope with elevated ROS levels and their deleterious consequences; however, our understanding of how response programs for protection from oxidative stress are coordinated across tissues remains quite limited.</p>
<p>Here, we investigate the role of neuronal signaling in mobilizing the transcriptional response to oxidative stress in the nematode <italic>Caenorhabditis elegans. C. elegans</italic> offers clear strengths for investigating oxidative stress responses and their regulation by the nervous system. Importantly, both neurotransmitter utilization (<xref ref-type="bibr" rid="c4">Bargmann, 1998</xref>) and the core stress response pathways are highly conserved from worms to humans (<xref ref-type="bibr" rid="c8">Blackwell et al., 2015</xref>; <xref ref-type="bibr" rid="c52">Murphy et al., 2003</xref>; <xref ref-type="bibr" rid="c72">van Heemst, 2010</xref>). Moreover, genetic disruptions in neural function are well-tolerated, allowing straightforward assessment of specific neuron classes, transmitter systems, and receptor types (<xref ref-type="bibr" rid="c4">Bargmann, 1998</xref>; <xref ref-type="bibr" rid="c13">Chun et al., 2015</xref>). Finally, survival assays for quantifying the organismal impacts of oxidative stress (<xref ref-type="bibr" rid="c35">Jia &amp; Sieburth, 2021</xref>; <xref ref-type="bibr" rid="c64">Senchuk et al., 2017</xref>; <xref ref-type="bibr" rid="c73">Van Raamsdonk &amp; Hekimi, 2009</xref>) and biochemical methods to assess oxidative damage (<xref ref-type="bibr" rid="c26">Goudeau &amp; Aguilaniu, 2010</xref>) are well-established. By combining straightforward stress assays with transcriptome profiling and the disruption of specific neurotransmitter systems, we explore organismal-level links between neuronal function and conserved pathways for oxidative stress regulation.</p>
<p>We show that extended oxidative stress mobilizes a broad transcriptional response, including the upregulation of canonical antioxidant and detoxification pathways, transcription factors, and genes involved in protein homeostasis. The transcriptional response to oxidative stress, most notably upregulation of genes associated with protein degradation through the proteasome, is severely blunted by either a deficiency of cholinergic neurotransmission or by mutation of the Gq-coupled muscarinic ACh receptor <italic>gar-3</italic> gene. Disruption of ACh signaling and mutation of <italic>gar-3</italic> produce similar decreases in survival during chronic oxidative stress, while specific overexpression of <italic>gar-3</italic> in cholinergic motor neurons offers protection. Together, our findings demonstrate the importance of neuronal cholinergic G<sub>q</sub>-coupled GPCR signaling for coordinating a cytoprotective oxidative stress response transcriptional program.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Neuronal silencing increases organismal vulnerability to chronic oxidative stress</title>
<p>To determine whether neurotransmission may impact organismal vulnerability to chronic oxidative stress, we measured the effects of neuronal silencing on longevity in the presence of the redox cycler paraquat. We first compared the longevity of wild-type animals treated with paraquat (PQ, 4 mM) from day 1 of adulthood. Consistent with prior work (<xref ref-type="bibr" rid="c20">Dues et al., 2016</xref>; <xref ref-type="bibr" rid="c62">Schaar et al., 2015</xref>; <xref ref-type="bibr" rid="c64">Senchuk et al., 2017</xref>; <xref ref-type="bibr" rid="c74">Van Raamsdonk &amp; Hekimi, 2012</xref>), we found that wild-type animals live up to ∼25 days under normal conditions, compared with approximately 15 days in the continued presence of PQ (<xref rid="figs1" ref-type="fig">Fig. S1A,B</xref>). The decrease in survival due to PQ treatment was partially reversed by supplementation with N-acetyl cysteine (NAC), a chemical precursor to the antioxidant glutathione (<xref ref-type="bibr" rid="c18">Desjardins et al., 2017</xref>) (<xref rid="figs1" ref-type="fig">Fig. S1C</xref>). To further implicate oxidative stress in the reduced longevity observed with PQ treatment, we next measured the survival of mutants deficient for the antioxidant gene superoxide dismutase 2 (<italic>sod-2</italic>) which are particularly siusceptible to oxidative damage (<xref ref-type="bibr" rid="c73">Van Raamsdonk &amp; Hekimi, 2009</xref>). The survival of <italic>sod-2</italic> mutants in the presence of PQ was significantly decreased compared to wild type controls (by nearly 50%) (<xref rid="figs1" ref-type="fig">Fig. S1D</xref>). Finally, we quantified protein carbonylation following extended PQ exposure as a measure of oxidative damage. We found that a 48 hr exposure to 4 mM PQ produces a striking increase in carbonylated/oxidized proteins (<xref rid="figs1" ref-type="fig">Fig. S1E</xref>). Together, our data demonstrate that extended PQ exposure substantially increases oxidative stress and damage, leading to reduced organismal survival.</p>
<p>Using pan-neuronal expression of the histamine-gated chloride channel HisCl1 to silence neuronal activity (<xref ref-type="bibr" rid="c59">Pokala et al., 2014</xref>), we sought to investigate the contribution of neuronal signaling to survival under oxidative stress conditions. We first asked whether neuronal silencing during the early stages of oxidative stress exposure altered organismal survival. Specifically, we exposed 1-day adults to 4 mM PQ for 48 hr prior to neuronal silencing (24 hr) in the continued presence of PQ. We found that neuronal silencing significantly decreased the survival of PQ-treated animals compared to PQ-treated controls that did not undergo neuronal silencing (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). Importantly, the same period silencing did not significantly affect lifespan in the absence of PQ (<xref rid="figs2" ref-type="fig">Fig. S2A</xref>). These results demonstrate that neuronal silencing during the early stages of chronic oxidative stress increases organismal susceptibility, suggesting that neuronal activity may play a protective role during chronic oxidative stress.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Neuronal activity protects from chronic oxidative stress</title><p><bold>(A)</bold> Top, experimental timeline indicating timing and duration of histamine and PQ treatment for survival assays. Left: Bar graph comparing IP50 measurements for control (His-) and His-treated (His+) <italic>kyEx4571</italic> (<italic>tag-168p</italic>::HisCl1::SL2::GFP) transgenic animals animals in the presence of PQ. The day at which His-treated animals reach half of their initial population is significantly advanced compared to control, indicating reduced survival. Each point represents one independent trial. Bars indicate mean ±SEM. <italic>*p=0.0135</italic>, unpaired two-tailed t-test with Welch’s correction. Number of independent trials: n=6. Right: Kaplan-Meier survival curves comparing His+ and His-groups. Pan-neuronal silencing (24 hr) during oxidative stress reduces survival in the continued presence of PQ. Kaplan-Meier curves are cumulative of 6 trials. <italic>****p= 3.4E-08</italic>, Fisher’s exact test at 50% of survival. Total number of animals: n= 59 (His-), 64 (His+).</p><p><bold>(B)</bold> Top, experimental timeline indicating timing and duration of histamine and PQ treatment for survival assays. Note 8 hr recovery period between the end of histamine treatment and the onset of PQ exposure. Left: Bar graph comparing (IP50 measurements for control (His-) and His-treated (His+) <italic>kyEx4571</italic> (<italic>tag-168p</italic>::HisCl1::SL2::GFP) transgenic animals animals in the presence of PQ. The day at which His-treated animals reach half of their initial population is significantly advanced compared to control, indicating reduced survival. Each point represents one independent trial. Bars indicate mean ± SEM. <italic>*p=0.0156</italic>, unpaired two-tailed t-test with Welch’s correction. Number of independent trials: n=6. Right: Kaplan-Meier survival curves comparing His+ and His-groups. Pan-neuronal silencing (24 hr) prior to the onset of oxidative stress reduces organismal survival in the continued presence of PQ. Kaplan-Meier curves are cumulative of 6 trials. <italic>****p= 1.20E-07</italic>, Fisher’s exact test at 50% of survival. Total number of animals, n= 82 (His-), 89 (His+).</p></caption>
<graphic xlink:href="628021v3_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>To determine when neuronal activity may be most important, we next assessed the effects of neuronal silencing prior to PQ exposure. Specifically, we silenced neuronal activity for 24 hr followed by an 8 hr recovery period, prior to PQ exposure (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>). Surprisingly, we found that neuronal silencing prior to the onset of oxidative stress also significantly decreased the survival of PQ-treated animals, but not controls without PQ treatment (<xref rid="figs2" ref-type="fig">Fig. S2B</xref>). Overall, our findings provide evidence that neural activity promotes organismal survival by protecting from oxidative damage. Interestingly, neuronal silencing prior to or during oxidative stress each reduce survival during chronic oxidative stress exposure, suggesting that activity may have roles both in acute responses to oxidative stress and in equipping the organism to mount an effective protective response.</p>
</sec>
<sec id="s2b">
<title>Disruption of either ACh or glutamate neurotransmission decreases survival to chronic oxidative stress</title>
<p>To determine whether specific neurotransmitter systems contribute preferentially toward this protective mechanism, we measured the survival of mutants deficient in various neurotransmitters, under chronic PQ exposure. We used available strains carrying mutations in biosynthetic machinery for specific neurotransmitters (dopamine, octopamine, serotonin, GABA, glutamate, acetylcholine). Critically, prior work demonstrated that the longevity of mutants deficient for any one of these signaling systems is not significantly reduced under control conditions, though disruption of GABA signaling produced a modest increase in lifespan (<xref ref-type="bibr" rid="c13">Chun et al., 2015</xref>). Of these, we found that disruption of either acetylcholine/ACh (VAChT/<italic>unc-17 mutant</italic>) or glutamate (VGluT/<italic>eat-4</italic> mutant) transmission reduced survival during chronic oxidative stress most severely (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). Importantly, we also confirmed prior findings that mutation of either <italic>unc-17</italic> or <italic>eat-4</italic> did not significantly alter longevity under control conditions (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>). Our results reveal the importance of signaling through the small molecule neurotransmitters ACh and glutamate in regulation of responses to chronic oxidative stress. In contrast, prior studies of acute oxidative stress implicated neuropeptide signaling in protection, while disruption of small molecule neurotransmitter signaling either had no appreciable involvement (<xref ref-type="bibr" rid="c35">Jia &amp; Sieburth, 2021</xref>) or prolonged survival (<xref ref-type="bibr" rid="c14">Cornell et al., 2024</xref>). The differences in findings across acute and chronic stress may point towards intriguing differences in the way organisms respond to stress conditions of differing duration.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Disruption of either glutamate or acetylcholine neurotransmission increases vulnerability to PQ</title><p><bold>(A)</bold> Left: Bar graph comparing IP50 measurements for the indicated genotypes. The day at which <italic>eat-4</italic> (glutamate), <italic>unc-17</italic> (acetylcholine) or <italic>unc-25</italic> (GABA) mutants reach half of their initial population is significantly advanced compared to control, indicating reduced survival. The reduction in IP50 is greatest for <italic>eat-4</italic> and <italic>unc-17</italic> mutants. Each point represents one independent trial. Bars indicate mean ± SEM. <italic>****p &lt;0.0001, eat-4(ky5); ****p&lt;0.0001, unc-17(e245); ***p=0.0006, unc-25(e156); p=0.2718 (ns), tdc-1(n3420); p=0.9128 (ns), tph-1(mg280); p=0.2104 (ns), cat-2(n4547).</italic> One-way ANOVA with Dunnett’s multiple comparisons test. Number of trials: n≥5. Right: Upper, table shows the six conserved neurotransmitters and corresponding mutant genes involved with either vesicular loading or neurotransmitter biosynthesis that were surveyed in the survival assays. Kaplan -Meier survival curves for wild type and indicated neurotransmitter-deficient mutants with chronic PQ exposure. Kaplan-Meier curves are cumulative of at least 5 trials. ****<italic>p=5.00E-06, eat-4(ky5); ****p=1.50E-12, unc-17(e245); ****p=2.40E-12, unc-25(e156); ****p=1.10E-08, tdc-1(n3420); p=0.2492 (ns), tph-1(mg280); ****p=4.30E-12, cat-2(n4547).</italic> Fisher’s exact test at 75% of survival. Total number of animals: n= 527(N2), 251 (<italic>eat-4</italic>), 155 (<italic>unc-17</italic>), 148 (<italic>unc-25</italic>), 155 (<italic>tdc-1</italic>), 205 (<italic>tph-1</italic>), 145 (<italic>cat-2</italic>).</p><p><bold>(B)</bold> Left: IP50 comparisons showing glutamate and acetylcholinedeficient mutants have no significant difference in their normal longevity. Each data point is one independent trial. Bars indicate mean ±SEM. <italic>p =0.9712(ns), eat-4(ky5); p=0.6226 (ns), unc-17(e245).</italic> One-way ANOVA with Dunnett’s multiple comparisons test. Number of trial ≥3. Right: Kaplan-Meier curve shows there is a modest reduction of longevity in <italic>unc-17(e245)</italic> and no difference in <italic>eat-4(ky5)</italic> compared to WT(N2). The difference in longevity for <italic>unc-17(e245)</italic> compared to WT(N2) was observed after 9 days. Kaplan-Meier curves are cumulative of at least 3 trials. <italic>p =0.2425(ns), eat-4(ky5), **p=0.0012, (unc-17(e245)</italic>. Fisher’s exact test at 50% of survival. Total number of animals: n=65, N2; 67, <italic>eat-4(ky5)</italic> and 80, <italic>unc-17(e245)</italic>.</p></caption>
<graphic xlink:href="628021v3_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>As ACh is the most widely used small molecule neurotransmitter in <italic>C. elegans</italic>, we focused our subsequent analyses on the role of cholinergic signaling. Since a complete elimination of ACh function in <italic>C. elegans</italic> is lethal (<xref ref-type="bibr" rid="c1">Alfonso et al., 1993</xref>), we used the severe hypomorphic <italic>unc-17(e245)</italic> allele in our initial studies. <italic>unc-17(e245)</italic> animals are developmentally delayed, and the increase in vulnerability to PQ we observed may therefore have arisen indirectly from a more generalized requirement for cholinergic signaling in organismal health. To address this issue, we also tested animals carrying the <italic>unc-17(e113)</italic> allele that disrupts the COE motif in the <italic>unc-17</italic> promoter region (<xref ref-type="bibr" rid="c41">Kratsios et al., 2011</xref>; <xref ref-type="bibr" rid="c65">Serrano-Saiz et al., 2020</xref>), (J. Rand, unpublished). This mutation strongly decreases expression of <italic>unc-17</italic>/VAChT in cholinergic motor neurons that innervate body wall musculature but has less impact on <italic>unc-17</italic> expression in other cholinergic neurons and, therefore has more limited impacts on overall organismal development/health. <italic>unc-17(e113)</italic> animals displayed heightened vulnerability to PQ with a similar IP50 value to <italic>unc-17(e245)</italic> mutants (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). These results suggest that a loss of ACh release from cholinergic motor neurons may be sufficient to enhance vulnerability to oxidative stress. Consistent with this interpretation, specific knockdown of <italic>unc-17</italic> expression in cholinergic motor neurons by RNAi also increased vulnerability to oxidative stress (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). Our results implicate ventral cord motor neurons as a key cellular source of ACh in mediating protection from oxidative damage.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Disruption of cholinergic transmission from motor neurons reduces survival during chronic oxidative stress</title><p><bold>(A)</bold> Bar graph comparing IP50 measurements on PQ for wild type, <italic>unc-17(e245)</italic>, <italic>unc-17(e113)</italic>, or motor neuron-specific knockdown of <italic>unc-17</italic> by RNAi. <italic>unc-17(e113)</italic> mutants with reduced <italic>unc-17</italic> expression in motor neurons or RNAi downregulation of <italic>unc-17</italic> in motor neurons each show significant reductions in IP50, comparable to that of severely hypomorphic <italic>unc-17(e245)</italic> mutants. Each data point is one independent trial. Bars indicate mean ±SEM. <italic>****p &lt;0.0001, unc-17(e245); ****p&lt;0.0001, unc-17(e113); *p =0.0224</italic>, <italic>unc-17β RNAi</italic>. One-way ANOVA with Dunnett’s multiple comparisons test. Number of trials, n≥4. Total number of animals: n= 303, N2; 200, <italic>unc-17(e245);</italic> 200, <italic>unc-17(e113)</italic>; and 91, <italic>unc-17β</italic> RNAi.</p><p><bold>(B)</bold> IP50 comparison of of wild type (WT), <italic>unc-17(e245),</italic> and <italic>unc-17(e113)</italic> show there is no significant reduction in longevity under control (PQ-) conditions though <italic>unc-17(e113)</italic> is more variably affected. Each data point is one independent trial. Bars indicate mean ±SEM. <italic>p= 0.7316 (ns), unc-17(e245); p=0.1826 (ns), unc-17(e113)</italic>. One-way ANOVA with Dunnett’s multiple comparisons test. Number of trials: n≥3. Total number of animals: n= 65 WT(N2); 80, <italic>unc-17(e245);</italic> 63<italic>, unc-17(e113)</italic>.</p></caption>
<graphic xlink:href="628021v3_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2c">
<title>Extended oxidative stress mobilizes a broad transcriptional response</title>
<p>To better understand the impacts of chronic oxidative stress and the associated organismal responses, we next analyzed transcriptomic changes in response to extended PQ exposure (48 hr) by bulk RNA-seq. Specifically, we performed RNA sequencing of wild-type day 3 adults under control conditions, or following PQ exposure for 48 hrs. This timepoint is well before the occurrence of any lethality in our population survival assyas. We found that extended oxidative stress remarkably affected the transcriptome. We observed broad expression changes (&gt;2-fold, padj&lt; 0.01, FDR &lt;0.01) encompassing more than 2,000 genes (1811 upregulated, 274 downregulated) after 2 days of PQ exposure (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>, <xref ref-type="supplementary-material" rid="tables1">Table S1</xref>). To analyze the representation of functional gene categories amongst the PQ-upregulated genes, we compared up and downregulated genes using WormCat 2.0 (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>). Genes involved in stress or detoxification responses were highly enriched amongst the genes upregulated by PQ exposure and represent approximately 9% of the total gene set (Table S2). In particular, Phase 2 detoxification genes were highly represented among the upregulated genes, including the known SKN-1 target <italic>gst-4</italic> (<xref ref-type="bibr" rid="c38">Kahn et al., 2008</xref>; <xref ref-type="bibr" rid="c70">Tullet et al., 2008</xref>), ten other glutathione transferases (GSTs), and 22 UDP-glucuronosyl transferases (UGTs) (<xref ref-type="supplementary-material" rid="tables1">Tables S1, S2</xref>). Predicted Phase 1 detoxification genes, including 18 cytochrome p450 enzymes (CYPs) were also enriched amongst the upregulated genes. Finally, we note that the SKN-1-independent, hypoxia and pathogen-stress-responsive flavin-containing monooxygenase <italic>fmo-2</italic> gene is among the PQ-upregulated genes, providing evidence for the involvement of additional stress-responsive transcriptional pathways (<xref ref-type="bibr" rid="c19">Doering et al., 2022</xref>; <xref ref-type="bibr" rid="c42">Leiser et al., 2015</xref>; <xref ref-type="bibr" rid="c75">Wani et al., 2021</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Extended oxidative stress mobilizes a broad transcriptional response</title><p><bold>(A)</bold> Heatmap shows clustering of treatment (PQ+) and control (PQ-) replicates for WT(N2). Number of replicates: n= 4 for both conditions.</p><p><bold>(B)</bold> Volcano plot (log<sub>2</sub>FoldChange, -log<sub>10</sub>padj) of differentially expressed genes following 48 hrs of PQ (4 mM) treatment compared to age-matched controls. Red: upregulated, Blue: Downregulated, Grey: not significantly different. Statistical cutoff for differential expression: FoldChange&gt;2, P<sub>adj</sub>&lt;0.01 and False Discovery Rate (FDR) &lt;0.01.</p><p><bold>(C)</bold> Functional categorization of upregulated and downregulated genes that showed differential expression following 48 hr PQ exposure in wild type. The transcription factor, stress response and proteolysis proteasome categories were most strongly enriched amongst the differentially expressed genes. Grey squares indicate no significant enrichment in that category. Gene-count and P-value scales as indicated. A larger radius indicates a higher number of genes in that category. A darker color indicates a more significant P value.</p></caption>
<graphic xlink:href="628021v3_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The robust transcriptional response to extended PQ exposure showed considerable overlap with previously reported responses for acute exposure to other oxidants such as the metalloid arsenite (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>, <xref ref-type="supplementary-material" rid="tables3">Table S3</xref>) (<xref ref-type="bibr" rid="c55">Oliveira et al., 2009</xref>), organic peroxide tBOOH (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>, <xref ref-type="supplementary-material" rid="tables4">Table S4</xref>) (<xref ref-type="bibr" rid="c55">Oliveira et al., 2009</xref>), and the phenolic compound juglone (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>, <xref ref-type="supplementary-material" rid="tables5">Table S5</xref>) (<xref ref-type="bibr" rid="c77">Wu et al., 2016</xref>), suggesting chronic and acute oxidative stress induce partially overlapping transcriptional responses. Arsenite mobilizes a largely SKN-1-dependent stress response, and tBOOH mobilizes a largely SKN-1-independent stress response (<xref ref-type="bibr" rid="c25">Goh et al., 2018</xref>; <xref ref-type="bibr" rid="c55">Oliveira et al., 2009</xref>). The overlap of both the arsenite and tBOOH transcriptomic responses with our findings suggests that both SKN-1-dependent and -independent pathways are mobilized in response to extended PQ oxidative stress.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Comparison of transcriptomic responses between acute and extended oxidative stresses</title><p><bold>(A)</bold> Venn diagram shows the extent of overlap between genes upregulated in the presence of arsenite (<xref ref-type="bibr" rid="c55">Oliveira et al., 2009</xref>) compared with genes we identified as upregulated in response to extended PQ exposure. Approximately 36% (43 out of 118) of genes upregulated by arsenite treatment were also upregulated by PQ. Representative factor 3.5, p &lt; 2.816e-14.</p><p><bold>(B)</bold> Venn diagram shows the extent of overlap between genes upregulated in the presence of tBOOH (<xref ref-type="bibr" rid="c55">Oliveira et al., 2009</xref>) compared with genes we identified as upregulated in response to extended PQ exposure. Approximately 29% (81 out of 281) of genes upregulated by tBOOH treatment are also upregulated by PQ. Representative factor 2.8, p &lt; 2.205e-18.</p><p><bold>(C)</bold> Venn diagram shows the extent of overlap between genes upregulated in the presence of juglone (<xref ref-type="bibr" rid="c77">Wu et al., 2016</xref>) compared with genes we identified as upregulated in response to extended PQ exposure. Approximately 13% (103 out of 811) of genes upregulated by juglone treatment are also upregulated by PQ. Representative factor 1.2, p &lt; 0.014.</p></caption>
<graphic xlink:href="628021v3_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The PQ-upregulated genes also included gene classes implicated in other stress-related processes. For instance, we identified numerous genes involved in proteolysis, including 120 predicted E3 ubiquitin ligases among the PQ-upregulated gene set. Additionally, many of the PQ-upregulated genes regulate transcription, including 50 predicted nuclear hormone receptor (<italic>nhr</italic>) genes and 38 genes encoding homeodomain transcription factors. As noted in prior oxidant response studies (<xref ref-type="bibr" rid="c47">Maremonti et al., 2019</xref>; <xref ref-type="bibr" rid="c50">Mesbahi et al., 2020</xref>; <xref ref-type="bibr" rid="c61">Sandhu et al., 2021</xref>), we found significant upregulation of genes encoding extracellular material, including collagen and cuticle proteins as well as CUB domain proteins. Interestingly, we also found significant enrichment of genes involved in neuronal function, including upregulation of genes involved in cholinergic signaling. In particular, we noted upregulation of the G-protein coupled muscarinic acetylcholine receptor (mAChR) <italic>gar-3</italic> gene (<xref ref-type="bibr" rid="c32">Hwang et al., 1999</xref>; <xref ref-type="bibr" rid="c67">Steger &amp; Avery, 2004</xref>) and the <italic>ric-3</italic> gene that encodes a chaperone broadly important for the synthesis and synaptic delivery of ionotropic nicotinic acetylcholine receptors (nAChR) (<xref ref-type="bibr" rid="c6">Biala et al., 2009</xref>; <xref ref-type="bibr" rid="c27">Halevi et al., 2002</xref>). Curiously, among the 274 genes we identified to be downregulated by extended PQ exposure, we observed the strongest enrichment for collagen genes (24 genes) and other genes involved in detoxification (<italic>gst-44</italic>, <italic>ugt-63</italic>, <italic>cyp-35B1</italic>) and defense against pathogens (<italic>thn-1</italic>, <italic>thn-2</italic>, <italic>irg-5</italic>, C32H11.3). Overall, we conclude that the transcriptional response to extended PQ exposure induces many of the same gene classes previously implicated in both SKN-1-dependent and - independent responses to acute oxidant exposure. Additionally, we note that a more broad recruitment of stress-responsive pathways may arise due to distinct impacts of PQ as an oxidant, the extended duration of oxidant treatment used for our studies, or a combination of both factors.</p>
</sec>
<sec id="s2d">
<title>Cholinergic transmission is required for mobilization of the transcriptional response to extended oxidative stress</title>
<p>Encouraged by our results indicating increased vulnerability to oxidative stress in mutants where cholinergic neurotransmission is disrupted, we next sought to define the involvement of cholinergic signaling in the transcriptional response to extended PQ exposure. As described above for wild type, we performed RNA sequencing of day-3 adult <italic>unc-17</italic> mutants under control conditions or following 48 hr of 4 mM PQ exposure. We found that extended oxidative stress mobilized a significant transcriptional response in <italic>unc-17(e113)</italic> mutants (<xref rid="fig6" ref-type="fig">Fig. 6</xref>, <xref ref-type="supplementary-material" rid="tables7">Table S7</xref>), but far fewer genes show altered expression in response to PQ in <italic>unc-17</italic> mutants compared with wild type (2,085 genes in wild type vs. 995 genes in <italic>unc-17</italic> mutant) (<xref rid="fig4" ref-type="fig">Figs. 4B</xref> and <xref rid="fig6" ref-type="fig">6B,D</xref>). Moreover, approximately 70% of the genes we identified to be upregulated in the wild-type transcriptional response to extended PQ exposure fail to upregulate in <italic>unc-17</italic> mutants (<xref ref-type="supplementary-material" rid="tables8">Table S8</xref>). Gene enrichment analysis showed that the stress response, transcription factor, and neuronal function categories are enriched amongst PQ-upregulated genes in <italic>unc-17</italic> mutants (<xref rid="fig6" ref-type="fig">Fig. 6C</xref>, <xref ref-type="supplementary-material" rid="tables7">Table S7</xref>), as in wild type. However, we noted substantial decreases in the number of upregulated genes contributing to each of these categories in <italic>unc-17</italic> mutants compared to the wild type. For example, the number of transcription factor genes significantly upregulated in the wild type are decreased by approximately 70% in <italic>unc-17</italic> mutants (126 in wild type compared with 35 in <italic>unc-17</italic> mutants). Genes in the neuronal function, metabolism, and extracellular material gene classes enriched in the wild-type transcriptional response to PQ are also reduced by approximately 70% in <italic>unc-17</italic> mutants. The stress response, cilia, and proteolysis/proteasome categories are exceptions to this pattern. Surprisingly, the stress response gene class is not as severely affected by <italic>unc-17</italic> mutation, ∼55% of the stress response genes we identified as upregulated in the wild-type transcriptional response to PQ are also upregulated in <italic>unc-17</italic> mutants. Conversely, the proteolysis/proteasome and cilia gene classes are more severely affected by disruption of ACh transmission. Only ∼20% of the proteolysis/proteasome genes and 13% of the cilia genes we found upregulated in the wild-type transcriptional response to PQ are also upregulated in <italic>unc-17</italic> mutants.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Acetylcholine deficiency blunts transcriptomic responses to oxidative stress</title><p>Whole worm RNA sequencing data shows 48h continuous exposure to PQ (4 mM) does not change the transcriptomic landscape in <italic>unc-17(e113)</italic> mutants as severely as in wild type.</p><p><bold>(A)</bold> Heatmap shows clustering of treatment (PQ+) and control (PQ-) replicates for <italic>unc-17(e113)</italic>. Number of replicates: n=3 for both conditions.</p><p><bold>(B)</bold> Volcano plot (log<sub>2</sub>FoldChange, -log<sub>10</sub>padj) of genes differentially expressed in <italic>unc-17(e113)</italic> mutants in response to 48 hrs of PQ (4 mM) treatment compared to age-matched controls. Red: upregulated, Blue: Downregulated, Grey: not significantly different. Statistical cutoff for differential expression FoldChange&gt;2, p<sub>adj</sub>&lt;0.01, and False Discovery Rate (FDR) &lt;0.01.</p><p><bold>(C)</bold> Functional categorization of differentially expressed genes (upregulated and downregulated) in <italic>unc-17(e113)</italic> mutants following 48 hr of PQ exposure. Grey squares indicate no significant enrichment in that category. Gene count and P-value scale as indicated. A larger radius corresponds to a higher number of genes in that category. A darker color corresponds to a more significant P value.</p><p><bold>(D)</bold> Venn diagram shows the intersection of upregulated genes in response to PQ for wild type (N2) (total 1811) and <italic>unc-17(e113)</italic> (total 788). 1,313 genes that are a part of the wild type transcriptional response to PQ fail to be upregulated in ACh-deficient <italic>e113</italic> mutants.</p><p><bold>(E)</bold> Venn diagram shows the intersection of PQ-responsive and ACh-dependent wild type genes compared with genes differentially expressed in <italic>unc-17(e113)</italic> versus wild type under control conditions without PQ treatment. 104 genes (14%) are shared between the two groups. Wild-type PQ-responsive genes that are no longer PQ-responsive in <italic>unc-17</italic> mutants are largely distinct from those differentially expressed between <italic>unc-17</italic> and wild type in the absence of PQ.</p></caption>
<graphic xlink:href="628021v3_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Interestingly, we also found that 290 additional genes, not included in the wild-type transcriptional response to PQ, are upregulated by PQ treatment in <italic>unc-17</italic> mutants (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>). These additional genes largely fall into the same functional categories defined by the wild-type transcriptional response, with stress response and metabolism gene categories showing significant enrichment (<xref ref-type="supplementary-material" rid="tables7">Tables S7 and S8</xref>). These findings suggest the interesting possibility that activation of metabolic and stress pathways in <italic>unc-17</italic> mutants is achieved through transcriptional activation of alternate genes and relies on mechanisms less strongly dependent on ACh transmission. Notably, we found upregulation of very few additional genes in the proteolysis/proteasome class, perhaps suggesting that regulation of proteostasis through this gene class is more strongly dependent on ACh neurotransmission. Overall, we conclude that the transcriptional response to extended oxidative stress is strikingly blunted in <italic>unc-17</italic> mutants. Transcriptional activation of stress response genes is less severely compromised compared to other pathways comprising the wild-type transcriptional response, while transcriptional activation of proteolysis genes is most strongly impacted by disruption of ACh transmission.</p>
<p>To explore the requirements for cholinergic signaling in activation of an oxidative stress response versus other potential requirements that are independent of stress regulation, we also compared the transcriptional profiles of D3 adult wild type and <italic>unc-17</italic> mutants raised under control conditions (in the absence of PQ treatment). We identified 741 genes to be differentially expressed (429 upregulated, 312 downregulated) in <italic>unc-17</italic> mutants versus wild type (<xref ref-type="supplementary-material" rid="tables6">Table S6</xref>). Gene enrichment analysis showed that the stress response, neuronal function, muscle function, and transmembrane transport categories are significantly enriched amongst the differentially expressed gene set (<xref ref-type="supplementary-material" rid="tables6">Table S6</xref>). However, only ∼14% of the genes differentially expressed in <italic>unc-17</italic> mutants under control conditions were also upregulated as part of the <italic>unc-17</italic>-dependent transcriptional response to PQ (<xref rid="fig6" ref-type="fig">Fig. 6E</xref>, <xref ref-type="supplementary-material" rid="tables9">Table S9</xref>), suggesting there is little overlap between the transcriptional requirement for cholinergic signaling under control versus stress conditions. We conclude that cholinergic signaling is important for the mobilization of a transcriptional response to extended oxidative stress that is largely independent of potential roles for ACh signaling in organismal development.</p>
</sec>
<sec id="s2e">
<title>Deletion of the muscarinic acetylcholine receptor <italic>gar-3</italic> gene decreases survival during chronic oxidative stress</title>
<p>We next sought to investigate potential mechanisms by which ACh mediates transcriptional activation of an oxidant response program. Interestingly, we noted several genes involved in acetylcholine signaling were significantly upregulated in the wild-type transcriptional response to PQ. These included the M1/M3/M5 family G<sub>q</sub> protein-coupled muscarinic acetylcholine receptor (mAChR) <italic>gar-3</italic> gene, the ionotropic nicotinic acetylcholine receptor (nAChR) subunit genes <italic>lev-8</italic> and <italic>acr-12</italic> (<xref ref-type="bibr" rid="c58">Petrash et al., 2013</xref>), and the <italic>ric-3</italic> gene that encodes a chaperone broadly required for the assembly and synaptic delivery of nicotinic acetylcholine receptors (<xref ref-type="bibr" rid="c6">Biala et al., 2009</xref>; <xref ref-type="bibr" rid="c27">Halevi et al., 2002</xref>), (<xref rid="fig7" ref-type="fig">Fig. 7A</xref>). Motivated by the transcriptomic studies, we asked whether impaired muscarinic or nicotinic signaling affected organismal vulnerability to chronic oxidative stress. Specifically, we quantified the survival of strains carrying deletion mutations in either <italic>gar-3</italic> or <italic>ric-3</italic> during chronic oxidative stress. While mutation of <italic>ric-3</italic> did not significantly alter survival during chronic PQ exposure, we observed a striking decrease in the survival of <italic>gar-3</italic> mutants in the presence of PQ (<xref rid="fig7" ref-type="fig">Fig. 7B</xref>). Further, the survival of <italic>gar-3;ric-3</italic> double mutants during PQ exposure was not appreciably different from that of <italic>gar-3</italic> single mutants (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>). Notably, we did not find a significant decrease in the longevity of <italic>gar-3</italic> mutants under control conditions (PQ-), suggesting a potential protective role for mAChR GAR-3 signaling against oxidative damage (<xref rid="fig7" ref-type="fig">Fig. 7D</xref>). These findings provide evidence that cholinergic activation of GAR-3 mAChR is important for resilience in the face of chronic oxidative stress. Consistent with this, we found that the survival of <italic>gar-3</italic> mutants in the presence of PQ was decreased to a similar extent as observed for <italic>unc-17</italic> mutants (<xref rid="fig7" ref-type="fig">Fig. 7E</xref>). Moreover, the survival of <italic>unc-17;gar-3</italic> double mutants in the presence of PQ was not significantly decreased compared to either single mutant (<xref rid="fig7" ref-type="fig">Fig 7F</xref>). Finally, transgenic expression of expression of a wild-type GAR-3::YFP transgene that includes approximately 7.5 kb of the endogenous <italic>gar-3</italic> promoter region restored the survival of <italic>gar-3</italic> mutants on PQ to wild-type levels (<xref rid="fig7" ref-type="fig">Fig 7G</xref>). Taken together, our findings demonstrate that the decreased survival of cholinergic-deficient mutants during chronic oxidant exposure occurs primarily due to deficits in cholinergic activation of the GAR-3 mAChR.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Cholinergic activation of GPCR signaling via mAChR GAR-3 promotes survival in the presence of oxidative stress</title><p><bold>(A)</bold> Bar graph showing ACh signaling genes upregulated in wild type in response to PQ. <italic>acr-12</italic> and <italic>lev-8</italic> iAChR subunit, chaperone <italic>ric-3</italic> and mAChR <italic>gar-3</italic> transcripts are significantly upregulated. The bar graph shows log2foldchange value for all detected ACh signaling gene transcripts (y axis).</p><p><bold>(B)</bold> Bar graph comparing IP50 measurements for wild type, <italic>gar-3(gk305)</italic> mAChR mutants and <italic>ric-3(hm9)</italic> chaperone mutants in the presence of PQ. Mutation of <italic>gar-3</italic> significantly reduces IP50 values compared to wild type, whereas the effect of <italic>ric-3(hm9)</italic> is variable. Each data point represents one independent trial. Bars indicate mean ±SEM. <italic>****p&lt;0.0001, gar-3(gk305); p= 0.0531(ns), ric-3(hm9).</italic> One-way ANOVA with Dunnett’s multiple comparisons test.</p><p><bold>(C)</bold> Bar graph comparing IP50 measurements for wild type, <italic>gar-3(gk305)</italic> mutants and <italic>gar-3</italic>;<italic>ric-3</italic> double mutants in the presence of PQ. The IP50 of <italic>gar-3</italic>;<italic>ric-3</italic> double mutants is similar to that of <italic>gar-3(gk305)</italic> single mutants. Each data point represents one independent trial. Bars indicate mean ± SEM. <italic>**p= 0.0044,</italic> WT (N2) <italic>vs.gar-3(gk305);ric-3(hm9); p=0.0961(ns) for gar-3(gk305) vs. gar-3(gk305);ric-3(hm9).</italic> One-way ANOVA with Tukey’s multiple comparisons test. Number of trials: n=4, N2; n=3, <italic>gar-3(gk305)</italic>; n=4, <italic>gar-3(gk305);ric-3(hm9)</italic>.</p><p><bold>(D)</bold> Bar graph comparing IP50 measurements for wild type and <italic>gar-3(gk305)</italic> mutants under control condition in the absence of PQ. <italic>gar-3</italic> mutants do not show an appreciable reduction in longevity compared to wild type under control (PQ-) conditions. Each data point represents one independent trial. Bars indicate mean ± SEM. <italic>p= 0.7377 (ns),</italic> unpaired two-tailed t-test with Welch’s correction. Number of trials: n= 3. Total number of animals: n= 65 WT(N2); 85, <italic>gar-3(gk305)</italic>.</p><p><bold>(E)</bold> Bar graph comparing IP50 measurements for wild type, <italic>unc-17(e245)</italic> and <italic>gar-3(gk305)</italic> mutants in the presence of PQ. Mutation of <italic>unc-17</italic> or <italic>gar-3</italic> reduces survival to a similar extent in the presence of PQ. Each data point represents one independent trial. Bars indicate mean ± SEM. <italic>****p&lt;0.0001</italic>, one-way ANOVA with Dunnett’s multiple comparisons test. Number of trials: n= 9, N2; 8, <italic>unc-17(e245)</italic>; 11, <italic>gar-3(gk305)</italic>.</p><p><bold>(F)</bold> Bar graph comparing IP50 measurements for wild type, <italic>unc-17(e245)</italic>, <italic>unc-17(e113)</italic>, <italic>gar-3(gk305)</italic> and each of the double mutant combinations in the presence of PQ. Combined mutation of <italic>gar-3</italic> and <italic>unc-17</italic> elicits a similar reduction in IP50 to that of either single mutant, providing evidence that <italic>unc-17</italic> and <italic>gar-3</italic> may act in the same pathway. Each data point represents one independent trial. Bars indicate mean ± SEM. ***p=0.0006, WT vs. <italic>unc-17(e245)</italic>; **<italic>p=0.0011</italic>, WT vs. <italic>unc-17(e113)</italic>; <italic>***p=0.0005</italic>, WT vs. <italic>gar-3(gk305)</italic>; <italic>p= 0.8811(ns) gar-3(gk305)</italic> vs. <italic>gar-3(gk305);unc-17(e245)</italic>; <italic>p= 0.9983 (ns) gar-3(gk305)</italic> vs. <italic>gar-3(gk305);unc-17(e113)</italic>; <italic>p=0.9312 (ns), unc-17(e245) vs. gar-3(gk305); p =0.9827(ns), unc-17(e113) vs. gar-3(gk305); p= 0.9997(ns), unc-17(e113) vs. gar-3(gk305);unc-17(e113) and p&gt;0.9999(ns), unc-17(e245) vs. gar-3(gk305);unc-17(e245).</italic> One-way ANOVA with Tukey’s multiple comparisons test. Number of trials: n≥3.</p><p><bold>(G)</bold> Bar graph comparing IP50 measurements for wild type, <italic>gar-3(gk305)</italic> mutants and transgenic <italic>gar-3</italic> mutants expressing <italic>gar-3(+)</italic>. Expression of wild type <italic>gar-3</italic> using the native <italic>gar-3</italic> promoter region normalizes the survival of <italic>gar-3</italic> mutants in the presence of PQ. Each data point is one independent trial. Bars indicate mean ± SEM. p =<italic>0.9585(ns)</italic>, WT vs. <italic>gar-3p::gar-3(+</italic>);<italic>gk305</italic> and ***p =0.0002, <italic>gar-3(gk305)</italic> vs. <italic>gar-3p::gar-3(+</italic>);<italic>gk305.</italic> One-way ANOVA with Tukey’s multiple comparisons test. Number of trials: n≥4.</p></caption>
<graphic xlink:href="628021v3_fig7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2f">
<title>Deletion of <italic>gar-3</italic> severely weakens the transcriptional response to extended oxidative stress</title>
<p>To determine the requirement for GAR-3 mAChR signaling in promoting the ACh-dependent transcriptional response to chronic oxidant exposure, we performed bulk RNA sequencing of day-3 adult <italic>gar-3</italic> deletion mutants under control conditions or following 48 hrs of 4 mM PQ exposure. We observed a significant transcriptional response to extended oxidative stress in <italic>gar-3</italic> mutants, but, as for <italic>unc-17</italic> mutants, noted far fewer PQ stress-responsive genes in <italic>gar-3</italic> mutants compared with wild type (2,085 genes in wild type vs. 1,004 genes in <italic>gar-3</italic> mutants) (<xref rid="fig4" ref-type="fig">Figs. 4B</xref>, <xref rid="fig8" ref-type="fig">8B</xref>). We identified 868 upregulated and 136 downregulated genes in <italic>gar-3</italic> mutants (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). Similar to our findings for <italic>unc-17</italic> mutants above, approximately 70% of the genes we identified to be upregulated in the wild-type transcriptional response to extended PQ exposure failed to upregulate in <italic>gar-3</italic> mutants (<xref ref-type="supplementary-material" rid="tables1">Tables S1 and S10</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Deficiency of cholinergic signaling via GAR-3 blunts transcriptomic responses to oxidative stress</title><p><bold>(A)</bold> Heatmap shows clustering of treatment (PQ+) and control (PQ-) replicates for <italic>gar-3(gk305)</italic>. Number of replicates n= 2 for both conditions.</p><p><bold>(B)</bold> Volcano plot (log<sub>2</sub>FoldChange, -log<sub>10</sub>padj) of genes differentially expressed in <italic>gar-3(gk305)</italic> mutants in response to 48 hr of PQ (4 mM) treatment compared to age-matched controls. Red: upregulated, Blue: Downregulated, Grey: not significantly different. Statistical cutoff for differential expression FoldChange&gt;2, P<sub>adj</sub>&lt;0.01 and False Discovery Rate (FDR) &lt;0.01.</p><p><bold>(C)</bold> Functional categorization of differentially expressed genes (upregulated and downregulated) in <italic>gar-3(gk305)</italic> mutants in the presence of extended PQ exposure. Grey squares indicate no significant enrichment in that category. Gene count and P-value scales as indicated. A larger radius corresponds to a higher number of genes in that category. A darker color corresponds to a more significant P value.</p><p><bold>(D)</bold> Venn diagram showing the intersection of upregulated genes in wild type (total 1811), <italic>unc-17(e113)</italic> (total 788), and <italic>gar-3(gk305)</italic> (total 868) in response to PQ. 1055 genes that are upregulated in the wild transcriptional respoinse to PQ fail to upregulate in both ACh-deficient <italic>unc-17</italic> and <italic>gar-3</italic> mAChR mutants.</p></caption>
<graphic xlink:href="628021v3_fig8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Notably, the stress response, transcription factor, and neuronal function categories were significantly enriched amongst PQ-upregulated genes in <italic>gar-3</italic> mutants (<xref rid="fig8" ref-type="fig">Fig. 8C</xref>, <xref ref-type="supplementary-material" rid="tables10">Table S10</xref>). Similar to <italic>unc-17</italic> mutants, the proteolysis proteasome and cilia categories were not represented amongst the enriched gene categories (<xref rid="fig6" ref-type="fig">Figs. 6C</xref>, <xref rid="fig8" ref-type="fig">8C</xref>). Roughly 250 genes upregulated in the wild-type transcriptional response to PQ were also upregulated in both <italic>unc-17(e113)</italic> and <italic>gar-3(gk305)</italic> mutant transcriptional responses (<xref rid="fig8" ref-type="fig">Fig. 8D</xref>, <xref ref-type="supplementary-material" rid="tables12">Table S12</xref>). These genes include oxidative stress response genes such as <italic>gst-4</italic>, <italic>gst-14,</italic> and the heavy metal stress response gene <italic>cdr-1</italic>, known to be regulated by SKN-1, suggesting SKN-1-dependent upregulation of detoxification genes occurs largely independent of cholinergic signaling through GAR-3.</p>
<p>We also identified 1,055 genes that were upregulated by PQ exposure in wild type, but failed to upregulate in both <italic>unc-17(e113)</italic> and <italic>gar-3(gk305)</italic> mutants (<xref ref-type="supplementary-material" rid="tables11">Table S11</xref>). We propose that transcriptional activation of these genes during extended oxidative stress requires cholinergic neurotransmission via GAR-3. Therefore, we expect enriched categories amongst this gene set will identify stress-responsive pathways that are regulated through muscarinic activation. We identified the antioxidant gene <italic>ctl-1</italic>, multiple detoxification genes (<italic>gst-20</italic>, <italic>ugt-34</italic>, <italic>cyp-13A6</italic>), and C-type lectins (<italic>clec-83</italic>, <italic>clec-160</italic>) within the group of stress-responsive genes that required cholinergic signaling and GAR-3 activation. In addition, the <italic>nhr-49</italic>-dependent, stress-responsive <italic>fmo-2</italic> gene (<xref ref-type="bibr" rid="c19">Doering et al., 2022</xref>; <xref ref-type="bibr" rid="c31">Huang et al., 2021</xref>; <xref ref-type="bibr" rid="c42">Leiser et al., 2015</xref>; <xref ref-type="bibr" rid="c75">Wani et al., 2021</xref>) failed to upregulate in both <italic>unc-17</italic> and <italic>gar-3</italic> mutants, suggesting transcriptional responses to oxidative stress mediated through <italic>nhr-49</italic> are at least partially dependent on ACh signaling and GAR-3 activation.</p>
<p>As the proteolysis proteosome category of genes appeared strongly dependent on ACh signaling and GAR-3 activation, we also further investigated genes in this group. Proteolysis proteasome genes that are upregulated by PQ exclusively in wild type primarily consist of E3 domain F box genes (<italic>fbxa-31</italic>, <italic>fbxb-22</italic>, <italic>fbxc-34</italic>). F-box proteins act as substrate adaptors for the S-phase kinase-associated protein 1 (SKP1)-cullin 1 (CUL1)-F-box protein (SCF) ubiquitin ligase complexes, which mediate proteasomal degradation of a diverse range of regulatory proteins. Our results therefore suggest that cholinergic signaling through the GAR-3 mAChR may regulate proteostasis during oxidative stress through upregulation of ubiquitin-dependent protein degradation.</p>
</sec>
<sec id="s2g">
<title><italic>gar-3</italic> overexpression in cholinergic motor neurons increases survival during chronic oxidative stress</title>
<p>To better define potential mechanisms for GAR-3 regulation of antioxidant responses, we next sought to analyze the cellular expression of the <italic>gar-3</italic> gene using a genome-edited reporter strain, <italic>gar-3(syb9584)</italic>, in which the SL2 splice leader and GFP coding sequence are inserted into the <italic>gar-3</italic> genomic locus. We noted <italic>gar-3</italic> expression in the nerve ring and motor neurons of the ventral nerve cord, as well as in body wall muscles and pharynx (<xref rid="fig9" ref-type="fig">Figs. 9A-C</xref>). Using strains that co-express <italic>gar-3::SL2::GFP</italic> with red fluorescent (mCherry) reporters, we determined that <italic>gar-3</italic> is expressed both cholinergic (<italic>acr-2p::mCherry</italic>) and GABAergic (<italic>unc-47p::mCherry</italic>) ventral cord motor neurons (<xref rid="fig9" ref-type="fig">Figs. 9D,E</xref>). Prior studies using a <italic>gar-3</italic> transcriptional reporter reported <italic>gar-3</italic> expression solely in cholinergic motor neurons (<xref ref-type="bibr" rid="c11">Chan et al., 2013</xref>). The more broad expression of <italic>gar-3</italic> in ventral cord motor neurons that we observe is consistent with prior single neuron RNA-seq findings (<xref ref-type="bibr" rid="c69">Taylor et al., 2021</xref>).</p>
<fig id="fig9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 9.</label>
<caption><title>Cholinergic motor neuron-specific overexpression of <italic>gar-3</italic> is sufficient to protect against oxidative damage</title><p><bold>(A)</bold> Confocal maximum intensity projection of the head region of an adult animal expressing genome-inserted <italic>gar-3::SL2::GFP</italic>. Note expression in nerve ring processes (white box) and in the pharynx. Anterior is to the left in all panels. Scale, 10 µm.</p><p><bold>(B)</bold> Confocal maximum intensity projection showing zoomed-in view of <italic>gar-3</italic> expression in nerve ring neuronal cell bodies. Scale, 10 µm.</p><p><bold>(C)</bold> Confocal maximum intensity projection of the midbody region showing expression in ventral nerve cord motor neurons and body wall muscles. Scale, 10 µm.</p><p><bold>(D)</bold> Confocal maximum intensity projections of a segment of the ventral nerve cord showing expression of <italic>gar-3</italic>::SL2::GFP in cholinergic motor neurons labeled by <italic>acr-2p::mCherry</italic>. White arrows indicate <italic>gar-3</italic> expressing cholinergic neurons. Scale bar, 10 μm.</p><p><bold>(E)</bold> Confocal maximum intensity projections of a segment of the ventral nerve cord showing expression of <italic>gar-3</italic>::SL2::GFP in GABAergic motor neurons labeled by <italic>unc-47p::mCherry</italic>. White arrows indicate <italic>gar-3</italic> expressing GABAergic neurons. Scale bar, 10 μm.</p><p><bold>(F)</bold> Bar graph comparing IP50 measurements for wild type wild type, <italic>unc-17(e113)</italic>, transgenic wild type animals overexpressing <italic>gar-3</italic> in cholinergic motor neurons (<italic>unc-17βp::gar-3</italic> OE) and transgenic <italic>unc-17</italic> mutants overexpressing <italic>gar-3</italic> in cholinergic motor neurons (<italic>unc-17βp::gar-3(+);unc-17</italic>) in the presence of PQ. Cholinergic overexpression of <italic>gar-3</italic> significantly increases survival compared to wild type. Mutation of <italic>unc-17</italic> reverts survival to the level of <italic>unc-17(e113)</italic> mutants. Each data point is one independent trial. Bars indicate mean ±SEM. <italic>****p&lt;0.0001,</italic> WT(N2) <italic>vs. unc-17(e113), and</italic> WT(N2) <italic>vs. unc-17βp::gar-3OE, and unc-17(e113) vs. unc-17βp::gar-3OE, and unc-17βp::gar-3OE vs. unc-17βp::gar-3OE;unc-17. ***p=0.0005,</italic> WT(N2) <italic>vs. unc-17βp::gar-3(+);unc-17. p=0.8673 (ns), unc-17(e113) vs. unc-17βp::gar-3OE;unc-17</italic>. One-way ANOVA with Tukey’s multiple comparisons test. Number of trials: n=19, WT(N2); 7, <italic>unc-17(e113); 10, unc-17</italic>βp<italic>::gar-3OE; 3, unc-17βp::gar-3(+);unc-17</italic>.</p></caption>
<graphic xlink:href="628021v3_fig9.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>As our expression studies indicated significant <italic>gar-3</italic> expression in ventral cord motor neurons, we next asked whether overexpression of <italic>gar-3</italic> may be sufficient to offer protection from oxidative damage and increase organismal survival during chronic PQ exposure. While pan-neuronal <italic>gar-3</italic> overexpression proved lethal, we were able to obtain viable strains overexpressing <italic>gar-3</italic> in a subset of cholinergic neurons, including ventral cord motor neurons. Transgenic animals injected with the <italic>unc-17βp::gar-3</italic> transgene (25 ng/µL) displayed strikingly increased survival in the presence of 4 mM PQ compared to either <italic>gar-3</italic> mutants or wild type. In contrast, overexpression of <italic>gar-3</italic> in cholinergic motor neurons of <italic>unc-17</italic> mutants did not extend survival. Indeed, transgenic <italic>unc-17</italic> mutants expressing <italic>unc-17βp::gar-3</italic> survived similarly to <italic>unc-17</italic> single mutants during chronic PQ exposure (<xref rid="fig9" ref-type="fig">Fig. 9F</xref>). Thus <italic>gar-3</italic> overexpression in cholinergic motor neurons is sufficient to elicit protection from oxidative stress as indicated by increased survival to PQ, and these protective effects are dependent on vesicular release of ACh.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Our studies reveal new mechanistic insights into neural regulation of organismal stress responses. Using temporally defined periods of neuronal silencing in combination with analyses of genetic mutants deficient for specific neurotransmitters, we demonstrate that neuronal activity prior to and in the early stages of stress exposure are each important for the activation of stress-responsive transcriptional programs that promote organismal resilience in the face of extended oxidative stress. Cholinergic transmission is key for mobilizing this transcriptional stress response program. Our transcriptomic and survival analyses provide evidence that cholinergic GAR-3 activation is particularly important for stress-responsive upregulation of genes important for ubiquitin-dependent protein degradation, offering insight into a potential circuit for inter-tissue control of proteostasis. Finally, we show that overexpression of GAR-3 in cholinergic motor neurons confers enhanced survival to chronic oxidative stress, perhaps pointing to cholinergic motor neurons as a critical cellular site of action for the regulation of antioxidant responses. Prior work has suggested that activation of extrasynaptic GAR-3 mAChRs by humoral ACh promotes presynaptic release from cholinergic motor neurons (<xref ref-type="bibr" rid="c10">Chan et al., 2012</xref>; <xref ref-type="bibr" rid="c11">Chan et al., 2013</xref>). Based on this finding and our data, we hypothesize that elevated synaptic release from cholinergic motor neurons through GAR-3 activation may be important for coordinating an organismal response to chronic oxidative stress. Notably, cholinergic neurons are among those reported to be most vulnerable to degeneration during the early stages of Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="c12">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="c15">Davies &amp; Maloney, 1976</xref>; <xref ref-type="bibr" rid="c51">Mufson et al., 2008</xref>). Our findings may point toward interesting links between cholinergic signaling, muscarinic activation, and oxidative stress-mediated degeneration during AD.</p>
<sec id="s3a">
<title>Basal neural activity may promote organismal survival through neurohormesis</title>
<p>Interestingly, neuronal silencing prior to or during the early stages of oxidative stress each decrease organismal survival, suggesting that neural activity may have roles both in acute responses to oxidative stress and in equipping the organism to mount an effective protective response. Neural activity and ROS production are intimately associated due to the high energetic cost of maintaining neuronal excitability (<xref ref-type="bibr" rid="c28">Harris et al., 2012</xref>; <xref ref-type="bibr" rid="c29">Hongpaisan et al., 2004</xref>). Prior work has demonstrated that neuronal adaptation to harsh environments is elicited through prior exposure to sub-lethal doses of particular stressors. In particular, neurons appear to retain a ‘memory’ from prior exposure to a low dosage of a stressor that enables the animals to defend against that stressor in high doses, a phenomenon known as ‘neurohormesis’ (<xref ref-type="bibr" rid="c48">Mattson &amp; Cheng, 2006</xref>; <xref ref-type="bibr" rid="c60">Robertson, 2004</xref>). An example of such ‘preconditioning’ is found in the protection of rat cerebellar granule cells from glutamate-mediated excitotoxicity where low level stimulation of NMDA receptors elicits activation of nuclear-factor kappaB (NF-kB), a transcription factor involved in protective responses to stress (<xref ref-type="bibr" rid="c36">Jiang et al., 2003</xref>). Notably, neurohormesis responses are often mediated through transcriptional regulation (<xref ref-type="bibr" rid="c34">Jeong et al., 2006</xref>; <xref ref-type="bibr" rid="c43">Liu et al., 2005</xref>; <xref ref-type="bibr" rid="c76">West et al., 2001</xref>). Given the broad transcriptional response to extended PQ exposure we observed, our finding that silencing prior to PQ treatment decreases survival may suggest a similar form of neuronal priming. We speculate that neural activity may induce a modest increase in ROS which primes a protective transcriptional response, preparing the animals to defend against future oxidative stress.</p>
</sec>
<sec id="s3b">
<title>Acute and chronic oxidative stress elicit distinct molecular responses</title>
<p>Prior work indicated that a deficiency in acetylcholine neurotransmission either had no effect (<xref ref-type="bibr" rid="c35">Jia &amp; Sieburth, 2021</xref>) or was protective (<xref ref-type="bibr" rid="c14">Cornell et al., 2024</xref>) in cases of acute oxidant exposure. Surprisingly, we found that ACh-deficient mutants had severely decreased survival to chronic oxidative stress, perhaps pointing to interesting mechanistic differences in the transcriptional programs initiated by acute versus chronic stress and how they are regulated by the nervous system. Though comparisons across these studies are complicated by the fact that different oxidants are known to elicit distinct transcriptional responses (<xref ref-type="bibr" rid="c25">Goh et al., 2018</xref>; <xref ref-type="bibr" rid="c55">Oliveira et al., 2009</xref>; <xref ref-type="bibr" rid="c77">Wu et al., 2016</xref>), we noted interesting differences between our transcriptome analyses of extended stress versus previous analyses of acute stress responses. While many of the same core antioxidant genes and detoxification gene classes are upregulated in both cases, we observed a much broader transcriptional response to extended exposure that encompassed additional gene categories. We suggest that cholinergic signaling recruits additional stress-responsive genes that are important for coping with the impacts of extended stress. The differences between transcriptional responses to acute and chronic oxidant exposure may have important implications for understanding organismal responses to different classes of stressors, for example, acute exposure to an environmental toxin versus extended stress associated with chronic disease.</p>
</sec>
<sec id="s3c">
<title>Cholinergic mAChR activation is required for upregulation of genes important for ubiquitin-dependent protein degradation</title>
<p>Our gene enrichment analysis demonstrated that several gene categories, including proteolysis/proteasome, transmembrane transport, and cilia gene classes, which were enriched in the wild-type transcriptional response were no longer enriched in the <italic>unc-17</italic> or <italic>gar-3</italic> transcriptional responses. The loss of enrichment for the proteolysis/proteasome gene class, particularly E3 ubiquitin ligases, is remarkable because this gene category was one of the three most strongly upregulated in the wild-type gene set. This suggests a more stringent requirement for cholinergic transmission in the upregulation of proteolysis/proteasome genes in response to extended stress. Maintaining protein homeostasis is critical for organismal health (<xref ref-type="bibr" rid="c40">Koga et al., 2011</xref>). Like other eukaryotes, <italic>C. elegans</italic> depend on the ubiquitin-proteasome system for selective and efficient degradation or recycling of damaged or unneeded proteins (<xref ref-type="bibr" rid="c56">Papaevgeniou &amp; Chondrogianni, 2014</xref>; <xref ref-type="bibr" rid="c68">Tanaka, 2009</xref>). The ACh-dependent upregulation of E3 ubiquitin ligases observed in our transcriptomic studies raises an intriguing link between cholinergic transmission and the regulation of proteostasis through the ubiquitin-proteasome system. Recent evidence has suggested interesting links between cholinergic neurotransmission and proteostasis in other contexts. For instance, recent work showed that depletion of <italic>C. elegans</italic> BAZ-2, ortholog of <italic>BAZ2B</italic> (bromodomain adjacent to zinc finger domain 2B), reduced toxicity and aggregation of aggregation-prone peptides associated with AD and poly-Q diseases (<xref ref-type="bibr" rid="c23">Gallrein et al., 2023</xref>). BAZ-2 is a negative regulator of ACh metabolism and signaling, suggesting ACh signaling promotes proteostasis. In support of this conclusion, the authors showed that acetylcholine treatment can augment proteostasis by induction of both the endoplasmic reticulum unfolded protein response and the ubiquitin-proteasome system. Similarly, increased cholinergic signaling onto <italic>C. elegans</italic> muscles induces calcium-dependent activation of the stress-responsive transcription factor HSF-1 and increased expression of cytoplasmic chaperones, resulting in suppression of protein misfolding (<xref ref-type="bibr" rid="c66">Silva et al., 2013</xref>). Our transcriptomic and survival data suggest that cholinergic signaling also regulates proteostasis during prolonged oxidative stress.</p>
</sec>
<sec id="s3d">
<title>Cholinergic activation of the GAR-3 mAChR promotes organismal survival</title>
<p>Our transcriptome analysis, survival assays and rescue experiments identified a critical role for GAR-3 in the mobilization of the transcriptional response to extended oxidative stress. Moreover, <italic>gar-3</italic> overexpression in cholinergic motor neurons increased survival during oxidative stress in an ACh-dependent manner. Collectively, these results provide evidence for muscarinic activation of a protective antioxidant transcriptional response. GAR-3 is most similar to vertebrate M1/M3/M5 mAChR (<xref ref-type="bibr" rid="c21">Eglen, 2006</xref>; <xref ref-type="bibr" rid="c39">Kato et al., 2021</xref>). Previous studies of a variety of mammalian cell types have provided evidence that activation of the muscarinic M3 receptor can reduce oxidative stress (<xref ref-type="bibr" rid="c16">De Sarno et al., 2003</xref>; <xref ref-type="bibr" rid="c17">De Sarno et al., 2005</xref>; <xref ref-type="bibr" rid="c22">Frinchi et al., 2019</xref>; <xref ref-type="bibr" rid="c24">Giordano et al., 2009</xref>). Our work demonstrates that muscarinic activation can promote organism-wide antioxidant defenses and suggests that muscarinic control of antioxidant responses is evolutionarily conserved. It is interesting to speculate that similar muscarinic signaling pathways may coordinate antioxidant responses across cell types in the brain, for example between neurons and glia. Therapeutic approaches targeting muscarinic receptors may therefore offer a path to combat neurodegenerative disease and other pathological conditions resulting from extended oxidative stress.</p>
</sec>
</sec>
<sec id="s4">
<title>Material and methods</title>
<sec id="s4a">
<title><italic>C. elegans</italic> strains and genetics</title>
<p>All <italic>C. elegans</italic> strains are derivatives of the N2 Bristol strain (wild type) and maintained under standard conditions at 20°C on nematode growth media plates (NGM) seeded with the <italic>E. coli</italic> strain OP50. A complete strain list is provided in <xref ref-type="supplementary-material" rid="tables13">Table S13</xref>. Transgenic strains were generated by microinjection of plasmids or PCR products into the gonad of young hermaphrodites (<xref ref-type="bibr" rid="c49">Mello et al., 1991</xref>).</p>
</sec>
<sec id="s4b">
<title>Molecular biology</title>
<p>Plasmids were constructed using the two-slot Gateway Cloning system (Invitrogen) and confirmed by restriction digestion and/or sequencing as appropriate. All plasmids and primers used in this work are described in Table 2 and Table 3 respectively.</p>
<p><bold>pKB1</bold> (<italic>punc-17βp::gar-3 cDNA</italic>) was created by recombining entry vector pENTR-<italic>unc-17β</italic> and pDEST-254 (<italic>gar-3</italic> cDNA vector construct). <italic>gar-3 cDNA</italic> was amplified from wild-type RNA using primers OMF2777(forward: 5’ATTAGGTACCATGCAGTCCTCTTCGTTGG3’) and OMF2778 (5’ GCTAGCCGGCCTAGTTGCGTCGGACATA3’) with Superscript 3 RNA synthesis kit (Invitrogen catalog number 12574026). Then the cDNA was ligated into Kpn1/MgoMIV restriction enzyme (NEB) digested pDEST-16 to generate pDEST-254. pKB1 was injected in wild type N2 at 20ng/µl concentration. <bold>pKB5</bold> (<italic>gar-3p::gar-3 cDNA</italic>) was created by recombining entry vector pENTR-83 and pDEST-187. An 8.5 kb region immediately upstream of <italic>gar-3</italic> ATG (initiation codon) was amplified from genomic DNA using primers OMF3151 (5’CACCCGAGGGTGTTGCTCATTTCTAAACA3’) and OMF3152 (5’CACCCCTCTCGTCTGTGGTGATCCTGTAA3’) and ligated into pENTR-D-TOPO vector (Thermo Fisher Scientific) to create <italic>gar-3</italic> promoter pENTR-83 (<xref ref-type="bibr" rid="c11">Chan et al., 2013</xref>). pDEST-187 was created by linearizing pSM.GFPnovo2 plasmid (gift from K. Mizomoto) and inserting the ccdB cassette. The <italic>gar-3p</italic>:<italic>gar-3::YFP::unc-54</italic> plasmid (PYL8) was a gift from R. Garcia.</p>
</sec>
<sec id="s4c">
<title>Chronic PQ exposure assay</title>
<p>Chronic PQ exposure assays were performed as described previosuly (<xref ref-type="bibr" rid="c64">Senchuk et al., 2017</xref>). PQ (Sigma-Aldrich CAS number: 75365-73-0 and Thermo Scientific CAS number: 1910-42-5) and FUDR (Sigma-Aldrich, CAS number: 50-91-9) were dissolved in dH2O and added to NGM to final concentrations of 4 mM and 100 µM respectively. Briefly, animals were raised at 20°C until adult day-1 stage, after which they were transferred onto plates containing 4 mM PQ and 100 µM FUDR. These plates were seeded with 10x concentrated <italic>E. coli</italic> OP50 culture and roughly 30 Day 1 adult animals were placed on each plate, limiting the potential impacts of oxidative stress on neuronal development. The number of animals that died on each plate was recorded each day and survign animals were transferred to new plates at regular intervals until no surving animals remained. Animals were scored as dead if they did not respond to nose or tail touch. Unless indicated otherwise, all chronic PQ exposure assays were repeated for at least 3 individual trials with at least 20 animals per trial.</p>
</sec>
<sec id="s4d">
<title>Statistical analyses</title>
<p>Kaplan-Meier survival curves were generated using the OASIS opensource platform (<ext-link ext-link-type="uri" xlink:href="https://sbi.postech.ac.kr/oasis/introduction/">https://sbi.postech.ac.kr/oasis/introduction/</ext-link>) (<xref ref-type="bibr" rid="c78">Yang et al., 2011</xref>). Fisher’s exact test was performed to determine the statistical significance of the differences in survival between experimental strains. Unless otherwise indicated, the p-values at 50% survival are reported for Fisher’s exact tests. For the Initial Population 50 (IP50) calculation, Kaplan-Meier survival curves were made for each trial with each genotype. The time taken to reach 50% of the initial population was calculated using the Kaplan-Meier estimator. For determining the statistical significance of the difference of IP50 values of different strains, the IP50 values were subjected to One-Way ANOVA with Dunnett’s or Tukey’s multiple comparisons test. Graphs were plotted using GraphPad Prism.</p>
</sec>
<sec id="s4e">
<title>Longevity assay</title>
<p>For longevity assays animals were staged in a similar way as the chronic PQ exposure assay described earlier. Instead of plates containing PQ, day 1 adult animals were placed on NGM agar plates containing FUDR (Sigma-Aldrich, CAS number 50-91-9) to a final concentration of 100 µM. Plates were seeded with 10x concentrated OP50. Surviving animals were transferred to fresh plates at regular intervals. The number of surviving animals was recorded as described earlier. Kaplan-Meier survival curves and statistical tests were performed as described above.</p>
</sec>
<sec id="s4f">
<title>Protein carbonyl measurement</title>
<p>The Oxyblot<sup>TM</sup> immunoblot approach was used to determine oxidative damage based on the detection of 2,4-dinitrophenylhydrazine derivatized carbonyls in protein(<xref ref-type="bibr" rid="c26">Goudeau &amp; Aguilaniu, 2010</xref>; <xref ref-type="bibr" rid="c54">Nasrallah et al., 2023</xref>). For age synchronization, large populations (2000-3000) were grown on 10x concentrated OP50 until gravid adulthood and bleached to collect eggs. After repeated washes with M9, the eggs were plated on NGM with 10X concentrated OP50 and grown at 20°C. Around 40 hours post hatch (L4 stage), 25 µl of 100 mM FUDR was added to the plates. Day 1 adult animals were transferred to 4 mM PQ or control plates the following day for a period of 48 hours. Treated animals (PQ +/-) were washed free of bacteria with M9 and resuspended in 1x PBS. Worm pellets were snap frozen with liquid N<sub>2</sub> and stored at -80°C. Samples were thawed in RIPA lysis buffer (ThermoFisher, #89900), and Halt protease inhibitor (ThermoFisher, #78429) and sonicated by Teflon homogenizer. The protein-containing supernatant was collected following centrifugation. Protein concentrations were determined by the DC protein assay (DC<sup>TM</sup> protein assay kit II 5000112), using BSA as a standard. The Oxyblot<sup>TM</sup> protein oxidation detection kit (Sigma-Aldrich S7150) was used to detect DNPH derivatized carbonyl protein per manufacturer instructions. Protein samples were incubated at room temperature with SDS and 2,4-dinitrophenylhydrazine (DNPH) for 15 mins. The samples were neutralized and 15-20 μg of the sample protein solution were loaded for electrophoresis using NuPage 4–12% gels (Life Technologies), transferred to nitrocellulose membranes (Life Technologies) under vacuum pressure, blocked with 5% fat-free milk in TBST and probed with a rabbit-anti DNPH polyclonal primary antibody and goat anti-rabbit IgG (HRP conjugated) antibody. Protein bands were visualized using a ChemiDoc MP Imaging System (Bio-Rad Laboratories, Inc.) and Supersignal<sup>TM</sup> West Femto (Thermo Scientific 34096) was used as the chemiluminescent substrate. DNPH derivatized protein intensity was normalized against tubulin and quantified using Fiji imaging software (<xref ref-type="bibr" rid="c63">Schindelin et al., 2012</xref>). Statistical significance was determined using an unpaired two tailed t-test with Welch’s correction. Plots were made with GraphPad Prism.</p>
</sec>
<sec id="s4g">
<title>NAC treatment</title>
<p><italic>N</italic>-acetylcysteine (NAC) (Sigma -Aldrich, CAS number: 616-91-1) was prepared in dH<sub>2</sub>O and added into NGM to a final concentration of 9 mM following a published protocol (<xref ref-type="bibr" rid="c18">Desjardins et al., 2017</xref>). Similarly, to prepare NAC+PQ plates, NAC and PQ were added to NGM to a final concentrations of 9 mM and 4 mM, respectively. Plates were seeded with 10x <italic>E. coli</italic> OP50 and Day 1 adult animals were transferred to plates containing either NAC or NAC+PQ. Survival curves and statisitical comparisons were performed as described above.</p>
</sec>
<sec id="s4h">
<title>Neuronal silencing and survival assay</title>
<p>Neuronal silencing was performed following the published protocol (<xref ref-type="bibr" rid="c59">Pokala et al., 2014</xref>). Briefly, transgenic animals expressing <italic>kyEx4571</italic> (<italic>tag168p::HisCl1::SL2::GFP; myo-3p::mCherry)</italic> were raised on plates containing 10 mM histamine dihydrochloride (Sigma-Aldrich, CAS number 56-92-8) for 24 hours at 20°C and exposed to 4 mM PQ at the indicated time period or maintained on control plates. Kaplan-Meier survival curves and IP50 calculations were performed as previosuly. Statistical comparisons were performed using two-tailed unpaired t-test with Welch’s correction.</p>
</sec>
<sec id="s4i">
<title>Whole-worm bulk RNA sequencing</title>
<sec id="s4i1">
<title>Animal harvesting and RNA extraction</title>
<p>Adult hermaphrodites were allowed to lay eggs for six hours. Synchronized progeny were grown on NGM plates seeded with OP50 for ∼30 hrs (L4) at 20°C. For transcriptomic comparisons of PQ treated to untreated control animals, roughly 1200 L4 stage animals were selected for each genotype. Day 1 adult animals were placed on either PQ (4mM) or control plates the following day. After 48 hours, PQ-treated and control animals were harvested. Worm pellets were snap-frozen in liquid nitrogen and stored at -80°C. Animals were lysed in 10% SDS, b-ME, 0.5 M EDTA, 1M Tris-HCl pH 7.5, 20 mg/ml Proteinase K. Total RNA was extracted with Trizol (ThermoFisher) and purified by RNAeasy columns (QIAGEN). RNA samples were frozen using liquid nitrogen and stored at -80°C.</p>
</sec>
<sec id="s4i2">
<title>Differential expression analysis and functional analysis of enriched genes</title>
<p>Quality checks of extracted RNA, cDNA synthesis, and preparation of libraries with fragmenting cDNA were performed by Novogene. Library selection was poly A tail-based, and a paired layout was used to prepare the libraries. mRNA was sequenced using the Illumina platform with Novaseq6000 instrument. FASTQ files were trimmed using Trimmomatic software and mapped onto reference <italic>C. elegans</italic> genome using STAR. All detected transcripts were quantified using RSEM, and differential expression was analyzed using DESeq2. The differential expression analysis was performed in collaboration with the Walker lab at UMass Chan Medical School. Cutoffs for differential expression were set to be fold change&gt;2, p<sub>adj</sub>&lt;0.01, FDR&lt;0.01. Gene enrichment analysis was performed using WormCat 2.0 (<ext-link ext-link-type="uri" xlink:href="http://www.wormcat.com">http://www.wormcat.com</ext-link>) (Holdorf et al., 2020).</p>
</sec>
</sec>
<sec id="s4j">
<title>Statistical analysis of gene set overlaps</title>
<p>A web-based bioinformatics tool (<ext-link ext-link-type="uri" xlink:href="https://bioinformatics.psb.ugent.be/webtools/Venn/">https://bioinformatics.psb.ugent.be/webtools/Venn/</ext-link>) was used to calculate the overlap of gene sets and to draw Venn diagrams. Venn diagrams were modified using Affinity Designer (Universal-Version 1.0.0). Statisitical comparisons of overlapping gene sets were performed by hypergeometric test (<ext-link ext-link-type="uri" xlink:href="http://nemates.org/MA/progs/overlap_stats.html">http://nemates.org/MA/progs/overlap_stats.html</ext-link>).</p>
</sec>
<sec id="s4k">
<title>Confocal imaging</title>
<p>Day 1 adult animals, expressing the endogenous reporter <italic>gar-3</italic>::SL2::GFP, were immobilized with levamisole (2 mM) on 5% agarose pads. For co-localization analyses, the endogenous <italic>gar-3</italic> reporter was crossed into either a transgenic cholinergic (<italic>Pacr-2::</italic>mCherry) or GABAergic (<italic>Punc-47::mCherry</italic>) reporter. All confocal images were acquired using a Yokogawa CSU-X1 spinning disk confocal on a Nikon NiE upright motorized microscope, Nikon 60x oil immersion objective and Prime BSI Express CMOS camera (Teledyne Vision Solutions). Images were acquired using Nikon Elements software. Whole animal volumes were imaged using the large-image tiling function. Acquisition parameters were as follows, 488 nm laser (GFP channel): power 5%, exposure time 800 ms, multiplier 25; 561 nm laser (mCherry channel): power 0.5%, exposure time 100 ms, multiplier 10. Post-processing and analysis of images was performed using Fiji ImageJ software (<xref ref-type="bibr" rid="c63">Schindelin et al., 2012</xref>).</p>
</sec>
</sec>

</body>
<back>
<sec id="s9">
<title>Supplemental figures</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Figure S1.</label>
<caption><title>Chronic exposure to 4mM paraquat (PQ) results in oxidative stress</title><p><bold>(A)</bold> Experimental timeline for PQ chronic exposure assay. Animals are continuously exposed to 4 mM paraquat (PQ). At day 0 of the experiment, animals are day 1 (D1) adults.</p><p><bold>(B)</bold> Chronic PQ exposure reduces <italic>C. elegans</italic> longevity. Kaplan-Meier curves comparing the longevity of wild type (WT) N2 animals under control conditions (PQ–) to survival on 4 mM PQ. Percentage survival (y-axis) is plotted as a function of time (x-axis). <italic>****p= 1.4E-12</italic>, Fisher’s exact test at 50% of survival. Total number of independent trials: n=6. The Kaplan-Meier curve is cumulative of all trials. Total number of animals over all trials: n= 112 (PQ-) and 136 (PQ+).</p><p><bold>(C)</bold> Left: IP50comparison between wild type animals exposed to either PQ (PQ+) or PQ+NAC. For all, IP50 indicates the time to reach half of the original population. Each data point is one independent trial. Bars indicate mean ± SEM. <italic>****p=0.0007</italic>, unpaired two-tailed t-test with Welch’s correction. Total number of independent trials n=7. Right: Kaplan-Meier survival curves comparing the profiles of animals exposed to either PQ (PQ+) or PQ+NAC. The antioxidant N-acetyl cysteine (NAC) enhances survival during chronic PQ treatment. Kaplan-Meier curve is cumulative of 7 trials. <italic>****p= 3.60E-12</italic>, Fisher’s exact test at 50% of survival. Total animals: n= 172 (PQ+), n=175 (PQ+NAC).</p><p><bold>(D)</bold> Left: IP50 comparison of wild type, <italic>sod-2(ok1030)</italic> and <italic>sod-2(gk257)</italic> treated with PQ. <italic>sod-2</italic> mutants mutants are hypersensitive to PQ. Each data point is one independent trial. Bars indicate mean ± SEM. <italic>***p= 0.0004 sod-2(ok1030), ****p&lt;0.0001 sod-2(gk257),</italic> one-way ANOVA with Dunnett’s multiple comparisons test. Total number of trials: n=5 (WT), n=4 for <italic>sod-2(ok1030)</italic> and <italic>sod-2(gk257).</italic> Right: Kaplan-Meier survival curves comparing wild type, <italic>sod-2(ok1030)</italic> and <italic>sod-2(gk257)</italic>. SOD-2 deficiency reduces survival during chronic PQ exposure. Kaplan-Meier curve is cumulative of at least 4 trials. <italic>****p= 1.1E-12</italic>, <italic>sod-2(ok1030)</italic>, <italic>****p=4.5E-13</italic>, <italic>sod-2(gk257)</italic>. Fisher’s exact test at 50% of survival. Total number of animals: n= 123, WT; 91, <italic>sod-2(ok1030)</italic>; 90, <italic>sod-2(gk257</italic>).</p><p><bold>(E)</bold> Immunoblotting data of protein carbonylation in wild type animals after 48 hr of PQ exposure (starting from D1 adult) compared to untreated controls. Left, Chemiluminescence image of the blot with primary antibody against dinitrophenylhydrazone (DNP) (top) and α-tubulin control (bottom). Right, The ratio of the area under the curve for DNP chemiluminescence in a particular lane relative to α-tubulin. Each data point indicates one trial. Bars indicate mean ± SEM.</p><p><italic>*p=0.0454</italic>, unpaired two-tailed t-test with Welch’s correction.</p></caption>
<graphic xlink:href="628021v3_figs1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Figure S2.</label>
<caption><title>Pharmacological silencing of pan-neuronal activity without exposure to oxidative stressor PQ has a nominal effect in the reduction of organismal longevity</title><p><bold>(A)</bold> Top, experimental timeline indicating the period of histamine-mediated neuronal silencing (24 hrs) at day 2 of the longevity assay. Left: Bar graph comparing IP50 measurements for control (His-) and His-treated (His+) <italic>kyEx4571</italic> (<italic>tag-168p</italic>::HisCl1::SL2::GFP) transgenic animals animals under control conditions (PQ-). The mean IP50 value is not significantly altered by histamine exposure, though variability increases in the His-treated group. Each data point represents one independent trial. Bars indicate mean ± SEM. <italic>p=0.1843 (ns)</italic>, unpaired two-tailed t-test with Welch’s correction. Number of trials: n=4. Right: Kaplan-Meier survival curves for control (His-) and His-treated (His+) groups. Modest differences in longevity are apparent after day 9 of the lifespan assay. Kaplan-Meier curves are cumulative of 4 trials. <italic>*p = 0.0241</italic>, Fisher’s exact test at 50% of survival. Total number of animals: n= 46 (His-), 49 (His+).</p><p><bold>(B)</bold> Top, experimental timeline indicating the periods of histamine-mediated neuronal silencing (24 hr) and recovery (8 hr). Left: Bar graph comparing IP50 measurements for control (His-) and His-treated (His+) <italic>kyEx4571</italic> (<italic>tag-168p</italic>::HisCl1::SL2::GFP) transgenic animals animals under control conditions (PQ-). Each data point represents one independent trial. Bars indicate mean ± SEM. p=0.3629 (ns), unpaired two-tailed t-test with Welch’s correction. Number of trials, n=6. Right: Kaplan-Meier survival curves comparing profiles of control (His-) and His-treated (His+). Kaplan-Meier curves are cumulative of 6 trials. <italic>*p = 0.0390</italic>, Fisher’s exact test at 50% of survival. Total number of animals: n=68 (His-),67 (His+).</p></caption>
<graphic xlink:href="628021v3_figs2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank members of the Francis lab (Shankar Ramachandran, Samuel Liu) for critical reading of the manuscript. We also thank Shankar Ramachandran, Christopher Lambert, Julia L. Russell, Michael Gorczyca, Lorris Ferrari and Will Joyce for technical assistance. Some nematode strains were provided by the Caenorhabditis Genetics Center which is funded by the NIH National Center for Research Resources.</p>
</ack>
<sec id="d1e2346" sec-type="additional-information">
<title>Additional information</title>
<sec id="s5">
<title>Contributions Summary</title>
<p>KB and MMF conceptualized and planned the experiments. Preliminary data supporting some studies were provided by JBR. The experiments and analyses were conducted by KB. Confocal imaging was performed by KB, CM and HR.. Protein carbonylation experiments were performed in collaboration with KW in RPW laboratory. DH and AKW aided with differential expression analyses and functional categorization of RNA-seq data. KB performed gene enrichment analyses and comparisons.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This research was supported by NIH R01NS064263 (MMF), NSF 1755019 (MMF), Oklahoma Center for the Advancement of Science and Technology (JBR) and NIH R01AG068670 (AKW).</p>
</sec>
</sec>
<sec id="suppd1e2346" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="tables1">
<label>Supplemental table 1.</label>
<caption>
<title>Differentially expressed genes in wild type (N2) under oxidative stress and their functional categories.</title>
</caption>
<media xlink:href="supplements/628021_file02.xlsx"/>
</supplementary-material>
<supplementary-material id="tables2">
<label>Supplemental table 2.</label>
<caption>
<title>Classification of stress-related genes upregulated in wild type (N2) under PQ-mediated oxidative stress.</title>
</caption>
<media xlink:href="supplements/628021_file03.xlsx"/>
</supplementary-material>
<supplementary-material id="tables3">
<label>Supplemental table 3.</label>
<caption>
<title>Comparison of the genes upregulated by arsenite treatment to the genes upregulated by PQ treatment.</title>
</caption>
<media xlink:href="supplements/628021_file04.xlsx"/>
</supplementary-material>
<supplementary-material id="tables4">
<label>Supplemental table 4.</label>
<caption>
<title>Comparison of the genes upregulated by tBOOH treatment to the genes upregulated by PQ treatment.</title>
</caption>
<media xlink:href="supplements/628021_file05.xlsx"/>
</supplementary-material>
<supplementary-material id="tables5">
<label>Supplemental table 5.</label>
<caption>
<title>Comparison of the genes upregulated by juglone treatment to the genes upregulated by PQ treatment.</title>
</caption>
<media xlink:href="supplements/628021_file06.xlsx"/>
</supplementary-material>
<supplementary-material id="tables6">
<label>Supplemental table 6.</label>
<caption>
<title>Differentially expressed genes in <italic>unc-17(e113)</italic> compared to the wild type (N2) in basal condition (w/o PQ).</title>
</caption>
<media xlink:href="supplements/628021_file07.xlsx"/>
</supplementary-material>
<supplementary-material id="tables7">
<label>Supplemental table 7.</label>
<caption>
<title>Differentially expressed genes in <italic>unc-17(e113)</italic> under oxidative stress and their functional categories.</title>
</caption>
<media xlink:href="supplements/628021_file08.xlsx"/>
</supplementary-material>
<supplementary-material id="tables8">
<label>Supplemental table 8.</label>
<caption>
<title>Overlap of upregulated genes between WT(N2) and <italic>unc-17(e113)</italic>.</title>
</caption>
<media xlink:href="supplements/628021_file09.xlsx"/>
</supplementary-material>
<supplementary-material id="tables9">
<label>Supplemental table 9.</label>
<caption>
<title>Genes that failed to upregulate in <italic>unc-17(e113)</italic> under PQ-mediated stress are largely different from differentially expressed genes in basal condition (w/o PQ).</title>
</caption>
<media xlink:href="supplements/628021_file10.xlsx"/>
</supplementary-material>
<supplementary-material id="tables10">
<label>Supplemental table 10.</label>
<caption>
<title>Differentially expressed genes in <italic>gar-3(gk305)</italic> under PQ-mediated oxidative stress and their functional categories.</title>
</caption>
<media xlink:href="supplements/628021_file11.xlsx"/>
</supplementary-material>
<supplementary-material id="tables11">
<label>Supplemental table 11.</label>
<caption>
<title>Functional enrichment of genes that fail to upregulate under PQ exposure in either <italic>unc-17(e113)</italic> or <italic>gar-3(gk305)</italic>.</title>
</caption>
<media xlink:href="supplements/628021_file12.xlsx"/>
</supplementary-material>
<supplementary-material id="tables12">
<label>Supplemental table 12.</label>
<caption>
<title>Genes that are upregulated in all three genotypes N2, <italic>unc-17(e113),</italic> and <italic>gar-3(gk305)</italic> in the presence of PQ.</title>
</caption>
<media xlink:href="supplements/628021_file13.xlsx"/>
</supplementary-material>
<supplementary-material id="tables13">
<label>Supplemental table 13.</label>
<caption>
<title>Strain list.</title>
</caption>
<media xlink:href="supplements/628021_file14.xlsx"/>
</supplementary-material>
<supplementary-material id="tables14">
<label>Supplemental table 14.</label>
<caption>
<title>Plasmid list.</title>
</caption>
<media xlink:href="supplements/628021_file15.xlsx"/>
</supplementary-material>
<supplementary-material id="tables15">
<label>Supplemental table 15.</label>
<caption>
<title>Primer list.</title>
</caption>
<media xlink:href="supplements/628021_file16.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alfonso</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Grundahl</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Duerr</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>H. P.</given-names></string-name>, &amp; <string-name><surname>Rand</surname>, <given-names>J. B</given-names></string-name></person-group>. (<year>1993</year>). <article-title>The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter</article-title>. <source>Science</source>, <volume>261</volume>(<issue>5121</issue>), <fpage>617</fpage>–<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1126/science.8342028</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Back</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Braeckman</surname>, <given-names>B. P.</given-names></string-name>, &amp; <string-name><surname>Matthijssens</surname>, <given-names>F</given-names></string-name></person-group>. (<year>2012</year>). <article-title>ROS in aging Caenorhabditis elegans: damage or signaling?</article-title> <source>Oxid Med Cell Longev</source>, <volume>2012</volume>, <fpage>608478</fpage>. <pub-id pub-id-type="doi">10.1155/2012/608478</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bar-Ziv</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Dutta</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Hruby</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sukarto</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Averbukh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Alcala</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Henderson</surname>, <given-names>H. R.</given-names></string-name>, <string-name><surname>Durieux</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tronnes</surname>, <given-names>S. U.</given-names></string-name>, <string-name><surname>Ahmad</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Bolas</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Perez</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dishart</surname>, <given-names>J. G.</given-names></string-name>, <string-name><surname>Vega</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Higuchi-Sanabria</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Dillin</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Glial-derived mitochondrial signals affect neuronal proteostasis and aging</article-title>. <source>Sci Adv</source>, <volume>9</volume>(<issue>41</issue>), <fpage>eadi1411</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.adi1411</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bargmann</surname>, <given-names>C. I</given-names></string-name></person-group>. (<year>1998</year>). <article-title>Neurobiology of the Caenorhabditis elegans genome</article-title>. <source>Science</source>, <volume>282</volume>(<issue>5396</issue>), <fpage>2028</fpage>–<lpage>2033</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5396.2028</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhatti</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Sehrawat</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mishra</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sidhu</surname>, <given-names>I. S.</given-names></string-name>, <string-name><surname>Navik</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Khullar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bhatti</surname>, <given-names>G. K.</given-names></string-name>, &amp; <string-name><surname>Reddy</surname>, <given-names>P. H</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives</article-title>. <source>Free Radic Biol Med</source>, <volume>184</volume>, <fpage>114</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2022.03.019</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biala</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liewald</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Ben-Ami</surname>, <given-names>H. C.</given-names></string-name>, <string-name><surname>Gottschalk</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Treinin</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2009</year>). <article-title>The conserved RIC-3 coiled-coil domain mediates receptor-specific interactions with nicotinic acetylcholine receptors</article-title>. <source>Mol Biol Cell</source>, <volume>20</volume>(<issue>5</issue>), <fpage>1419</fpage>–<lpage>1427</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e08-08-0851</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biswas</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Alexander</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Francis</surname>, <given-names>M. M</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Reactive Oxygen Species: Angels and Demons in the Life of a Neuron</article-title>. <source>NeuroSci</source>, <volume>3</volume>(<issue>1</issue>), <fpage>130</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.3390/neurosci3010011</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blackwell</surname>, <given-names>T. K.</given-names></string-name>, <string-name><surname>Steinbaugh</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Hourihan</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Ewald</surname>, <given-names>C. Y.</given-names></string-name>, &amp; <string-name><surname>Isik</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2015</year>). <article-title>SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans</article-title>. <source>Free Radic Biol Med</source>, <volume>88</volume>(<issue>Pt B</issue>), <fpage>290</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.06.008</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname>, <given-names>X</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease</article-title>. <source>Nat Rev Immunol</source>, <volume>16</volume>(<issue>1</issue>), <fpage>35</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2015.8</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chan</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>Z.</given-names></string-name>, &amp; <string-name><surname>Sieburth</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Recruitment of sphingosine kinase to presynaptic terminals by a conserved muscarinic signaling pathway promotes neurotransmitter release</article-title>. <source>Genes Dev</source>, <volume>26</volume>(<issue>10</issue>), <fpage>1070</fpage>–<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.1101/gad.188003.112</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chan</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Staab</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mazzasette</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Butte</surname>, <given-names>Z.</given-names></string-name>, &amp; <string-name><surname>Sieburth</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Extrasynaptic muscarinic acetylcholine receptors on neuronal cell bodies regulate presynaptic function in Caenorhabditis elegans</article-title>. <source>J Neurosci</source>, <volume>33</volume>(<issue>35</issue>), <fpage>14146</fpage>–<lpage>14159</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1359-13.2013</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>Z. R.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>S. L.</given-names></string-name>, &amp; <string-name><surname>Hong</surname>, <given-names>F. F</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Role of Cholinergic Signaling in Alzheimer’s Disease</article-title>. <source>Molecules</source>, <volume>27</volume>(<issue>6</issue>). <pub-id pub-id-type="doi">10.3390/molecules27061816</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chun</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gong</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>X. Z.</given-names></string-name>, &amp; <string-name><surname>Liu</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Metabotropic GABA signalling modulates longevity in C. elegans</article-title>. <source>Nat Commun</source>, <volume>6</volume>, <fpage>8828</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms9828</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cornell</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Harradine</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Godini</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Handley</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Pocock</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2024</year>). <article-title>Neuro-intestinal acetylcholine signalling regulates the mitochondrial stress response in Caenorhabditis elegans</article-title>. <source>Nat Commun</source>, <volume>15</volume>(<issue>1</issue>), <fpage>6594</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-50973-y</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davies</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Maloney</surname>, <given-names>A. J</given-names></string-name></person-group>. (<year>1976</year>). <article-title>Selective loss of central cholinergic neurons in Alzheimer’s disease</article-title>. <source>Lancet</source>, <volume>2</volume>(<issue>8000</issue>), <fpage>1403</fpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(76)91936-x</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Sarno</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Shestopal</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>King</surname>, <given-names>T. D.</given-names></string-name>, <string-name><surname>Zmijewska</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Jope</surname>, <given-names>R. S.</given-names></string-name></person-group> (<year>2003</year>). <article-title>Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition</article-title>. <source>J Biol Chem</source>, <volume>278</volume>(<issue>13</issue>), <fpage>11086</fpage>–<lpage>11093</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M212157200</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Sarno</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Shestopal</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Zmijewska</surname>, <given-names>A. A.</given-names></string-name>, &amp; <string-name><surname>Jope</surname>, <given-names>R. S.</given-names></string-name></person-group> (<year>2005</year>). <article-title>Anti-apoptotic effects of muscarinic receptor activation are mediated by Rho kinase</article-title>. <source>Brain Res</source>, <volume>1041</volume>(<issue>1</issue>), <fpage>112</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.01.081</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Desjardins</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Cacho-Valadez</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yee</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bernard</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Khaki</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Breton</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Hekimi</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Antioxidants reveal an inverted U-shaped dose-response relationship between reactive oxygen species levels and the rate of aging in Caenorhabditis elegans</article-title>. <source>Aging Cell</source>, <volume>16</volume>(<issue>1</issue>), <fpage>104</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12528</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doering</surname>, <given-names>K. R. S.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Milburn</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ratnappan</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ghazi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>D. L.</given-names></string-name>, &amp; <string-name><surname>Taubert</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Nuclear hormone receptor NHR-49 acts in parallel with HIF-1 to promote hypoxia adaptation in Caenorhabditis elegans</article-title>. <source>eLife</source>, <volume>11</volume>. <pub-id pub-id-type="doi">10.7554/eLife.67911</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dues</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Andrews</surname>, <given-names>E. K.</given-names></string-name>, <string-name><surname>Schaar</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Bergsma</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Senchuk</surname>, <given-names>M. M.</given-names></string-name>, &amp; <string-name><surname>Van Raamsdonk</surname>, <given-names>J. M.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Aging causes decreased resistance to multiple stresses and a failure to activate specific stress response pathways</article-title>. <source>Aging (Albany NY)</source>, <volume>8</volume>(<issue>4</issue>), <fpage>777</fpage>–<lpage>795</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100939</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eglen</surname>, <given-names>R. M</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function</article-title>. <source>Auton Autacoid Pharmacol</source>, <volume>26</volume>(<issue>3</issue>), <fpage>219</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-8673.2006.00368.x</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frinchi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nuzzo</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Scaduto</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Di Carlo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Massenti</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Belluardo</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name><surname>Mudo</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Anti-inflammatory and antioxidant effects of muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus</article-title>. <source>Sci Rep</source>, <volume>9</volume>(<issue>1</issue>), <fpage>14233</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-50708-w</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallrein</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>A. B.</given-names></string-name>, <string-name><surname>Meyer</surname>, <given-names>D. H.</given-names></string-name>, <string-name><surname>Messling</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Schumacher</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2023</year>). <article-title>baz-2 enhances systemic proteostasis in vivo by regulating acetylcholine metabolism</article-title>. <source>Cell Rep</source>, <volume>42</volume>(<issue>12</issue>), <fpage>113577</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2023.113577</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giordano</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>White</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>Farin</surname>, <given-names>F. M.</given-names></string-name>, <string-name><surname>Wilkerson</surname>, <given-names>H. W.</given-names></string-name>, <string-name><surname>Kavanagh</surname>, <given-names>T. J.</given-names></string-name>, &amp; <string-name><surname>Costa</surname>, <given-names>L. G</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells</article-title>. <source>J Neurochem</source>, <volume>109</volume>(<issue>2</issue>), <fpage>525</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.05969.x</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goh</surname>, <given-names>G. Y. S.</given-names></string-name>, <string-name><surname>Winter</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Bhanshali</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Doering</surname>, <given-names>K. R. S.</given-names></string-name>, <string-name><surname>Lai</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Veal</surname>, <given-names>E. A.</given-names></string-name>, &amp; <string-name><surname>Taubert</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2018</year>). <article-title>NHR-49/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting</article-title>. <source>Aging Cell</source>, <volume>17</volume>(<issue>3</issue>), <fpage>e12743</fpage>. <pub-id pub-id-type="doi">10.1111/acel.12743</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goudeau</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Aguilaniu</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Carbonylated proteins are eliminated during reproduction in C. elegans</article-title>. <source>Aging Cell</source>, <volume>9</volume>(<issue>6</issue>), <fpage>991</fpage>–<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00625.x</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Halevi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>McKay</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Palfreyman</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yassin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Eshel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jorgensen</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Treinin</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2002</year>). <article-title>The C. elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors</article-title>. <source>EMBO J</source>, <volume>21</volume>(<issue>5</issue>), <fpage>1012</fpage>–<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/21.5.1012</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harris</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Jolivet</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Attwell</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Synaptic energy use and supply</article-title>. <source>Neuron</source>, <volume>75</volume>(<issue>5</issue>), <fpage>762</fpage>–<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.019</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hongpaisan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Winters</surname>, <given-names>C. A.</given-names></string-name>, &amp; <string-name><surname>Andrews</surname>, <given-names>S. B</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons</article-title>. <source>J Neurosci</source>, <volume>24</volume>(<issue>48</issue>), <fpage>10878</fpage>–<lpage>10887</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3278-04.2004</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Bian</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Rong</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>H. S.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mei</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Wang</surname>, <given-names>P. Y</given-names></string-name></person-group>. (<year>2023</year>). <article-title>JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens</article-title>. <source>Front Bioeng Biotechnol</source>, <volume>11</volume>, <fpage>1110765</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2023.1110765</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Howington</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Dobry</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>C. R.</given-names></string-name>, &amp; <string-name><surname>Leiser</surname>, <given-names>S. F</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Flavin-Containing Monooxygenases Are Conserved Regulators of Stress Resistance and Metabolism</article-title>. <source>Front Cell Dev Biol</source>, <volume>9</volume>, <fpage>630188</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.630188</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>U. S.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>Y. S.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>Y. S.</given-names></string-name>, <string-name><surname>Kaang</surname>, <given-names>B. K.</given-names></string-name>, &amp; <string-name><surname>Cho</surname>, <given-names>N. J</given-names></string-name></person-group>. (<year>1999</year>). <article-title>Cloning and functional characterization of a Caenorhabditis elegans muscarinic acetylcholine receptor</article-title>. <source>Recept Channels</source>, <volume>6</volume>(<issue>6</issue>), <fpage>415</fpage>–<lpage>424</lpage>. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/10635059">https://www.ncbi.nlm.nih.gov/pubmed/10635059</ext-link></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Irazoqui</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Troemel</surname>, <given-names>E. R.</given-names></string-name>, <string-name><surname>Feinbaum</surname>, <given-names>R. L.</given-names></string-name>, <string-name><surname>Luhachack</surname>, <given-names>L. G.</given-names></string-name>, <string-name><surname>Cezairliyan</surname>, <given-names>B. O.</given-names></string-name>, &amp; <string-name><surname>Ausubel</surname>, <given-names>F. M</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus</article-title>. <source>PLoS Pathog</source>, <volume>6</volume>(<issue>7</issue>), <fpage>e1000982</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000982</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jeong</surname>, <given-names>W. S.</given-names></string-name>, <string-name><surname>Jun</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Kong</surname>, <given-names>A. N</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Nrf2: a potential molecular target for cancer chemoprevention by natural compounds</article-title>. <source>Antioxid Redox Signal</source>, <volume>8</volume>(<issue>1-2</issue>), <fpage>99</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2006.8.99</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname>, <given-names>Q.</given-names></string-name>, &amp; <string-name><surname>Sieburth</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Mitochondrial hydrogen peroxide positively regulates neuropeptide secretion during diet-induced activation of the oxidative stress response</article-title>. <source>Nat Commun</source>, <volume>12</volume>(<issue>1</issue>), <fpage>2304</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-22561-x</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Okagaki</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lipsky</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Banaudha</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mearow</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Strauss</surname>, <given-names>K. I.</given-names></string-name>, &amp; <string-name><surname>Marini</surname>, <given-names>A. M</given-names></string-name></person-group>. (<year>2003</year>). <article-title>N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons</article-title>. <source>Ann N Y Acad Sci</source>, <volume>993</volume>, <fpage>134</fpage>–<lpage>145</lpage>; discussion 159-160. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2003.tb07522.x</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Juan</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Perez de la Lastra</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Plou</surname>, <given-names>F. J.</given-names></string-name>, &amp; <string-name><surname>Perez-Lebena</surname>, <given-names>E.</given-names></string-name></person-group> (<year>2021</year>). <article-title>The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies</article-title>. <source>Int J Mol Sci</source>, <volume>22</volume>(<issue>9</issue>). <pub-id pub-id-type="doi">10.3390/ijms22094642</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kahn</surname>, <given-names>N. W.</given-names></string-name>, <string-name><surname>Rea</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Moyle</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kell</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Johnson</surname>, <given-names>T. E</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans</article-title>. <source>Biochem J</source>, <volume>409</volume>(<issue>1</issue>), <fpage>205</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20070521</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kato</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kolotuev</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Cunha</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gharib</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Sternberg</surname>, <given-names>P. W</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Extrasynaptic acetylcholine signaling through a muscarinic receptor regulates cell migration</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>118</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1073/pnas.1904338118</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koga</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kaushik</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Cuervo</surname>, <given-names>A. M</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Protein homeostasis and aging: The importance of exquisite quality control</article-title>. <source>Ageing Res Rev</source>, <volume>10</volume>(<issue>2</issue>), <fpage>205</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2010.02.001</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kratsios</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Stolfi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Levine</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Hobert</surname>, <given-names>O</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Coordinated regulation of cholinergic motor neuron traits through a conserved terminal selector gene</article-title>. <source>Nat Neurosci</source>, <volume>15</volume>(<issue>2</issue>), <fpage>205</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2989</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leiser</surname>, <given-names>S. F.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Rossner</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Fletcher</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Leonard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Primitivo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rintala</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ramos</surname>, <given-names>F. J.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>D. L.</given-names></string-name>, &amp; <string-name><surname>Kaeberlein</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Cell nonautonomous activation of flavin-containing monooxygenase promotes longevity and health span</article-title>. <source>Science</source>, <volume>350</volume>(<issue>6266</issue>), <fpage>1375</fpage>–<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.1126/science.aac9257</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Narasimhan</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name><surname>Chan</surname>, <given-names>P. H</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin</article-title>. <source>Stroke</source>, <volume>36</volume>(<issue>6</issue>), <fpage>1264</fpage>–<lpage>1269</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.0000166180.91042.02</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, &amp; <string-name><surname>Tian</surname>, <given-names>Y</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Two sensory neurons coordinate the systemic mitochondrial stress response via GPCR signaling in C. elegans</article-title>. <source>Dev Cell</source>, <volume>57</volume>(<issue>21</issue>), <fpage>2469</fpage>–<lpage>2482.e2465.</lpage> <pub-id pub-id-type="doi">10.1016/j.devcel.2022.10.001</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hoeffer</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Massaad</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Iadecola</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Murphy</surname>, <given-names>M. P.</given-names></string-name>, <string-name><surname>Pautler</surname>, <given-names>R. G.</given-names></string-name>, &amp; <string-name><surname>Klann</surname>, <given-names>E</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Amyloid beta-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide</article-title>. <source>J Neurosci</source>, <volume>31</volume>(<issue>15</issue>), <fpage>5589</fpage>–<lpage>5595</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6566-10.2011</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Manoharan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Guillemin</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Abiramasundari</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Essa</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Akbar</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Akbar</surname>, <given-names>M. D</given-names></string-name></person-group>. (<year>2016</year>). <article-title>The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease: A Mini Review</article-title>. <source>Oxid Med Cell Longev</source>, <volume>2016</volume>, <fpage>8590578</fpage>. <pub-id pub-id-type="doi">10.1155/2016/8590578</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maremonti</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Eide</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Oughton</surname>, <given-names>D. H.</given-names></string-name>, <string-name><surname>Salbu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Grammes</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Kassaye</surname>, <given-names>Y. A.</given-names></string-name>, <string-name><surname>Guedon</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lecomte-Pradines</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Brede</surname>, <given-names>D. A</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Gamma radiation induces life stage-dependent reprotoxicity in Caenorhabditis elegans via impairment of spermatogenesis</article-title>. <source>Sci Total Environ</source>, <volume>695</volume>, <fpage>133835</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2019.133835</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mattson</surname>, <given-names>M. P.</given-names></string-name>, &amp; <string-name><surname>Cheng</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses</article-title>. <source>Trends Neurosci</source>, <volume>29</volume>(<issue>11</issue>), <fpage>632</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2006.09.001</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mello</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>Kramer</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Stinchcomb</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Ambros</surname>, <given-names>V</given-names></string-name></person-group>. (<year>1991</year>). <article-title>Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences</article-title>. <source>EMBO J</source>, <volume>10</volume>(<issue>12</issue>), <fpage>3959</fpage>–<lpage>3970</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1991.tb04966.x</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mesbahi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Pho</surname>, <given-names>K. B.</given-names></string-name>, <string-name><surname>Tench</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Leon Guerrero</surname>, <given-names>V. L.</given-names></string-name>, &amp; <string-name><surname>MacNeil</surname>, <given-names>L. T</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Cuticle Collagen Expression Is Regulated in Response to Environmental Stimuli by the GATA Transcription Factor ELT-3 in Caenorhabditis elegans</article-title>. <source>Genetics</source>, <volume>215</volume>(<issue>2</issue>), <fpage>483</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.120.303125</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mufson</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Counts</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Perez</surname>, <given-names>S. E.</given-names></string-name>, &amp; <string-name><surname>Ginsberg</surname>, <given-names>S. D</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications</article-title>. <source>Expert Rev Neurother</source>, <volume>8</volume>(<issue>11</issue>), <fpage>1703</fpage>–<lpage>1718</lpage>. <pub-id pub-id-type="doi">10.1586/14737175.8.11.1703</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murphy</surname>, <given-names>C. T.</given-names></string-name>, <string-name><surname>McCarroll</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Bargmann</surname>, <given-names>C. I.</given-names></string-name>, <string-name><surname>Fraser</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kamath</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Ahringer</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Kenyon</surname>, <given-names>C</given-names></string-name></person-group>. (<year>2003</year>). <article-title>Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans</article-title>. <source>Nature</source>, <volume>424</volume>(<issue>6946</issue>), <fpage>277</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1038/nature01789</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nandi</surname>, <given-names>I.</given-names></string-name>, &amp; <string-name><surname>Aroeti</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Mitogen-Activated Protein Kinases (MAPKs) and Enteric Bacterial Pathogens: A Complex Interplay</article-title>. <source>Int J Mol Sci</source>, <volume>24</volume>(<issue>15</issue>). <pub-id pub-id-type="doi">10.3390/ijms241511905</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nasrallah</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Peterson</surname>, <given-names>N. D.</given-names></string-name>, <string-name><surname>Szumel</surname>, <given-names>E. S.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Page</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Tse</surname>, <given-names>S. Y.</given-names></string-name>, <string-name><surname>Wani</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Tocheny</surname>, <given-names>C. E.</given-names></string-name>, &amp; <string-name><surname>Pukkila-Worley</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans</article-title>. <source>PLoS Pathog</source>, <volume>19</volume>(<issue>10</issue>), <fpage>e1011730</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1011730</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oliveira</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>Porter Abate</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dilks</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Landis</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ashraf</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Murphy</surname>, <given-names>C. T.</given-names></string-name>, &amp; <string-name><surname>Blackwell</surname>, <given-names>T. K</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Condition-adapted stress and longevity gene regulation by Caenorhabditis elegans SKN-1/Nrf</article-title>. <source>Aging Cell</source>, <volume>8</volume>(<issue>5</issue>), <fpage>524</fpage>–<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2009.00501.x</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Papaevgeniou</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name><surname>Chondrogianni</surname>, <given-names>N</given-names></string-name></person-group>. (<year>2014</year>). <article-title>The ubiquitin proteasome system in Caenorhabditis elegans and its regulation</article-title>. <source>Redox Biol</source>, <volume>2</volume>, <fpage>333</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2014.01.007</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paulsen</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Truong</surname>, <given-names>T. H.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>F. J.</given-names></string-name>, <string-name><surname>Homann</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gupta</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Leonard</surname>, <given-names>S. E.</given-names></string-name>, &amp; <string-name><surname>Carroll</surname>, <given-names>K. S</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity</article-title>. <source>Nat Chem Biol</source>, <volume>8</volume>(<issue>1</issue>), <fpage>57</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.736</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petrash</surname>, <given-names>H. A.</given-names></string-name>, <string-name><surname>Philbrook</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Haburcak</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Barbagallo</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Francis</surname>, <given-names>M. M</given-names></string-name></person-group>. (<year>2013</year>). <article-title>ACR-12 ionotropic acetylcholine receptor complexes regulate inhibitory motor neuron activity in Caenorhabditis elegans</article-title>. <source>J Neurosci</source>, <volume>33</volume>(<issue>13</issue>), <fpage>5524</fpage>–<lpage>5532</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4384-12.2013</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pokala</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Gordus</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Bargmann</surname>, <given-names>C. I</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Inducible and titratable silencing of Caenorhabditis elegans neurons in vivo with histamine-gated chloride channels</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>111</volume>(<issue>7</issue>), <fpage>2770</fpage>–<lpage>2775</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1400615111</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robertson</surname>, <given-names>R. M</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Modulation of neural circuit operation by prior environmental stress</article-title>. <source>Integr Comp Biol</source>, <volume>44</volume>(<issue>1</issue>), <fpage>21</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1093/icb/44.1.21</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sandhu</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Badal</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sheokand</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Tyagi</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Singh</surname>, <given-names>V</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Specific collagens maintain the cuticle permeability barrier in Caenorhabditis elegans</article-title>. <source>Genetics</source>, <volume>217</volume>(<issue>3</issue>). <pub-id pub-id-type="doi">10.1093/genetics/iyaa047</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaar</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Dues</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Spielbauer</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Machiela</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Cooper</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Senchuk</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hekimi</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Van Raamsdonk</surname>, <given-names>J. M.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Mitochondrial and cytoplasmic ROS have opposing effects on lifespan</article-title>. <source>PLoS Genet</source>, <volume>11</volume>(<issue>2</issue>), <fpage>e1004972</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1004972</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schindelin</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Arganda-Carreras</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Frise</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kaynig</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Longair</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pietzsch</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Preibisch</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rueden</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Saalfeld</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schmid</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Tinevez</surname>, <given-names>J. Y.</given-names></string-name>, <string-name><surname>White</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Hartenstein</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Eliceiri</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Tomancak</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Cardona</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source>Nat Methods</source>, <volume>9</volume>(<issue>7</issue>), <fpage>676</fpage>-<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Senchuk</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Dues</surname>, <given-names>D. J.</given-names></string-name>, &amp; <string-name><surname>Van Raamsdonk</surname>, <given-names>J. M.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Measuring Oxidative Stress in Caenorhabditis elegans: Paraquat and Juglone Sensitivity Assays</article-title>. <source>Bio Protoc</source>, <volume>7</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.21769/BioProtoc.2086</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Serrano-Saiz</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Gulez</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Pereira</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gendrel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kerk</surname>, <given-names>S. Y.</given-names></string-name>, <string-name><surname>Vidal</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Kratsios</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Rand</surname>, <given-names>J. B.</given-names></string-name>, &amp; <string-name><surname>Hobert</surname>, <given-names>O</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Modular Organization of Cis-regulatory Control Information of Neurotransmitter Pathway Genes in Caenorhabditis elegans</article-title>. <source>Genetics</source>, <volume>215</volume>(<issue>3</issue>), <fpage>665</fpage>–<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.120.303206</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Silva</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Amaral</surname>, <given-names>M. D.</given-names></string-name>, &amp; <string-name><surname>Morimoto</surname>, <given-names>R. I</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Neuronal reprograming of protein homeostasis by calcium-dependent regulation of the heat shock response</article-title>. <source>PLoS Genet</source>, <volume>9</volume>(<issue>8</issue>), <fpage>e1003711</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003711</pub-id></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Steger</surname>, <given-names>K. A.</given-names></string-name>, &amp; <string-name><surname>Avery</surname>, <given-names>L</given-names></string-name></person-group>. (<year>2004</year>). <article-title>The GAR-3 muscarinic receptor cooperates with calcium signals to regulate muscle contraction in the Caenorhabditis elegans pharynx</article-title>. <source>Genetics</source>, <volume>167</volume>(<issue>2</issue>), <fpage>633</fpage>–<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.103.020230</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tanaka</surname>, <given-names>K</given-names></string-name></person-group>. (<year>2009</year>). <article-title>The proteasome: overview of structure and functions</article-title>. <source>Proc Jpn Acad Ser B Phys Biol Sci</source>, <volume>85</volume>(<issue>1</issue>), <fpage>12</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.2183/pjab.85.12</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taylor</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Santpere</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Weinreb</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Barrett</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Reilly</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Varol</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Oikonomou</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Glenwinkel</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>McWhirter</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Poff</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Basavaraju</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rafi</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Yemini</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Abrams</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Vidal</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Cros</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tavazoie</surname>, <given-names>S.</given-names></string-name>, <etal>…</etal> <string-name><surname>Miller</surname>, <given-names>D. M</given-names></string-name></person-group>., <edition>3rd</edition>. (<year>2021</year>). <article-title>Molecular topography of an entire nervous system</article-title>. <source>Cell</source>, <volume>184</volume>(<issue>16</issue>), <fpage>4329</fpage>-<lpage>4347.e4323.</lpage> <pub-id pub-id-type="doi">10.1016/j.cell.2021.06.023</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tullet</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Hertweck</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>An</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Baker</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hwang</surname>, <given-names>J. Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Oliveira</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>Baumeister</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Blackwell</surname>, <given-names>T. K</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans</article-title>. <source>Cell</source>, <volume>132</volume>(<issue>6</issue>), <fpage>1025</fpage>–<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.01.030</pub-id></mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valko</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Izakovic</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mazur</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rhodes</surname>, <given-names>C. J.</given-names></string-name>, &amp; <string-name><surname>Telser</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Role of oxygen radicals in DNA damage and cancer incidence</article-title>. <source>Mol Cell Biochem</source>, <volume>266</volume>(<issue>1-2</issue>), <fpage>37</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1023/b:mcbi.0000049134.69131.89</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Heemst</surname>, <given-names>D.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Insulin, IGF-1 and longevity</article-title>. <source>Aging Dis</source>, <volume>1</volume>(<issue>2</issue>), <fpage>147</fpage>-<lpage>157</lpage>. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22396862">https://www.ncbi.nlm.nih.gov/pubmed/22396862</ext-link></mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van Raamsdonk</surname>, <given-names>J. M.</given-names></string-name>, &amp; <string-name><surname>Hekimi</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2009</year>). <article-title>Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans</article-title>. <source>PLoS Genet</source>, <volume>5</volume>(<issue>2</issue>), <fpage>e1000361</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000361</pub-id></mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van Raamsdonk</surname>, <given-names>J. M.</given-names></string-name>, &amp; <string-name><surname>Hekimi</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Superoxide dismutase is dispensable for normal animal lifespan</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>109</volume>(<issue>15</issue>), <fpage>5785</fpage>–<lpage>5790</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1116158109</pub-id></mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wani</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Goswamy</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Taubert</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ratnappan</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ghazi</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Irazoqui</surname>, <given-names>J. E</given-names></string-name></person-group>. (<year>2021</year>). <article-title>NHR-49/PPAR-alpha and HLH-30/TFEB cooperate for C. elegans host defense via a flavin-containing monooxygenase</article-title>. <source>eLife</source>, <volume>10</volume>. <pub-id pub-id-type="doi">10.7554/eLife.62775</pub-id></mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>West</surname>, <given-names>A. E.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>W. G.</given-names></string-name>, <string-name><surname>Dalva</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Dolmetsch</surname>, <given-names>R. E.</given-names></string-name>, <string-name><surname>Kornhauser</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Shaywitz</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Takasu</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Tao</surname>, <given-names>X.</given-names></string-name>, &amp; <string-name><surname>Greenberg</surname>, <given-names>M. E</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Calcium regulation of neuronal gene expression</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>98</volume>(<issue>20</issue>), <fpage>11024</fpage>–<lpage>11031</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.191352298</pub-id></mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>C. W.</given-names></string-name>, <string-name><surname>Deonarine</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Przybysz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Strange</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Choe</surname>, <given-names>K. P</given-names></string-name></person-group>. (<year>2016</year>). <article-title>The Skp1 Homologs SKR-1/2 Are Required for the Caenorhabditis elegans SKN-1 Antioxidant/Detoxification Response Independently of p38 MAPK</article-title>. <source>PLoS Genet</source>, <volume>12</volume>(<issue>10</issue>), <fpage>e1006361</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006361</pub-id></mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Nam</surname>, <given-names>H. J.</given-names></string-name>, <string-name><surname>Seo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>S. K.</given-names></string-name>, <string-name><surname>Choi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Nam</surname>, <given-names>H. G.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S. J.</given-names></string-name>, &amp; <string-name><surname>Kim</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2011</year>). <article-title>OASIS: online application for the survival analysis of lifespan assays performed in aging research</article-title>. <source>PLoS One</source>, <volume>6</volume>(<issue>8</issue>), <fpage>e23525</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0023525</pub-id></mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>W. S.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>K. J.</given-names></string-name>, <string-name><surname>Gaschler</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Patel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Shchepinov</surname>, <given-names>M. S.</given-names></string-name>, &amp; <string-name><surname>Stockwell</surname>, <given-names>B. R</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>113</volume>(<issue>34</issue>), <fpage>E4966</fpage>–<lpage>4975</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1603244113</pub-id></mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Gan</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Paik</surname>, <given-names>J. H</given-names></string-name></person-group>. (<year>2011</year>). <article-title>FoxO family members in cancer</article-title>. <source>Cancer Biol Ther</source>, <volume>12</volume>(<issue>4</issue>), <fpage>253</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.4161/cbt.12.4.15954</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107726.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kratsios</surname>
<given-names>Paschalis</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Chicago</institution>
</institution-wrap>
<city>Chicago</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>useful</bold> study advances our understanding of how organisms respond to chronic oxidative stress. Using the nematode C. elegans, the authors identified key neuronal signaling molecules and their receptors that are required for stress signaling and survival. The evidence supporting the conclusions is <bold>solid</bold>, with rigorous genetics, stress response analysis, and transcriptional profiling. This research will be of broad interest to neuroscientists and researchers working in the field of oxidative stress regulation.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107726.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The researchers aimed to identify which neurotransmitter pathways are required for animals to withstand chronic oxidative stress. This work thus has important implications for disease processes that are caused/linked to oxidative stress. This work identified specific neurotransmitters and receptors that coordinate stress resilience, both prior to and during stress exposure. Further, the authors identified specific transcriptional programs coordinated by neurotransmission that may provide stress resistance.</p>
<p>Strengths:</p>
<p>The manuscript is very clearly written with a well-formulated rationale. Standard C. elegans genetic analysis and rescue experiments were performed to identify key regulators of the chronic oxidative stress response. These findings were enhanced by transcriptional profiling that identified differentially expressed genes that likely affect survival when animals are exposed to stress.</p>
<p>Weaknesses:</p>
<p>Where the gar-3 promoter drives expression was not discussed in the context of the rescue experiments in Figure 7.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107726.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this paper, Biswas et al. describe the role of acetylcholine (ACh) signaling in protection against chronic oxidative stress in C. elegans. They showed that disruption of ACh signaling in either unc-17 mutants or gar-3 mutants led to sensitivity to toxicity caused by chronic paraquat (PQ) treatment. Using RNA seq, they found that approximately 70% of the genes induced by chronic PQ exposure in wild type failed to upregulate in these mutants. The overexpression of gar-3 selectively in cholinergic neurons was sufficient to promote protection against chronic PQ exposure in an ACh-dependent manner. The study points to a previously undescribed role for ACh signaling in providing organism-wide protection from chronic oxidative stress, likely through the transcriptional regulation of numerous oxidative stress-response genes. The paper is well-written, and the data are robust, though some conclusions seem preliminary and do not fully support the current data. While the study identifies the muscarinic ACh receptor gar-3 as an important regulator of the response to PQ, the specific neurons in which gar-3 functions were not unambiguously identified, and the sources of ACh that regulate GAR-3 signaling and the identities of the tissues targeted by gar-3 were not addressed, limiting the scope of the study.</p>
<p>Major Comments:</p>
<p>(1) The site of action of cholinergic signaling for protection from PQ was not adequately explored. The authors' conclusion that cholinergic motor neurons are protective is based on studies using overexpression of gar-3 and an unc-17 allele that may selectively disrupt ACh in cholinergic motor neurons (Figure 9F), but these approaches are indirect. To more directly address the site of action, the authors should conduct rescue experiments using well-defined heterologous promoters. Figure 7G shows that gar-3 expressed under a 7.5 kb promoter fragment fully rescues the defect of gar-3 mutants, but the authors did not report where this promoter fragment is expressed, nor did they conduct rescue experiments of the specific tissues where gar-3 is known to be expressed (cholinergic neurons, GABAergic neurons, pharynx, or muscles). UNC-17 rescue experiments could also be useful to address the site of action. Does expression of unc-17 selectively in cholinergic motor neurons rescue the stress sensitivity of unc-17 mutants (or restore resistance to gar-3(OE); unc-17 mutants)? These experiments may also address whether ACh acts in an autocrine or paracrine manner to activate gar-3, which would be an important mechanistic insight to this study that is currently lacking.</p>
<p>(2) The genetic pan-neuronal silencing experiments presented in Figure 1 motivated the subsequent experiments, but the authors did not relate these observations to ACh/gar-3 signaling. For example, the authors did not address whether silencing just the cholinergic motor neurons at the different times tested has the same effects on survival as pan-neuronal silencing.</p>
<p>(3) It is assumed that protection occurs through inter-tissue signaling of ACh to target tissues, where it impacts gene expression. While this is a reasonable assumption, it has not been directly shown here. It is recommended that the authors examine GFP reporter expression of a sampling of the genes identified in this study (including proteasomal genes that the authors highlight) that are regulated by unc-17 and gar-3. This would serve to independently confirm the RNAseq data and to identify target tissues that are subject to gene expression regulation by ACh, which would significantly strengthen the study.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107726.1.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Biswas</surname>
<given-names>Kasturi</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7243-1422</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Caroline</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1099-5721</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Rogers</surname>
<given-names>Hannah</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0008-8485-7138</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Wani</surname>
<given-names>Khursheed A</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3559-7962</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Pukkila-Worley</surname>
<given-names>Read</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5340-8294</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Higgins</surname>
<given-names>Daniel P</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4660-354X</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Walker</surname>
<given-names>Amy K</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1899-8916</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Mullen</surname>
<given-names>Gregory P</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rand</surname>
<given-names>James B</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Francis</surname>
<given-names>Michael M</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8076-6668</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Recommendations for the authors):</bold></p>
<p>“The gar-3 promoter expression pattern was not discussed in the context of rescue experiments.”</p>
</disp-quote>
<p>We agree that the expression pattern of the gar-3 promoter used in our rescue experiments should be clarified. We will include a description of the tissues where the 7.5 kb gar-3 promoter fragment is expressed, based on both prior studies and our own expression data. We will also discuss how the gar-3 cell and tissue expression pattern relates to both our analysis of gar-3 expression in the genome edited strain we generated as well as the observed rescue effects.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the authors):</bold></p>
<p>(1) The site of action of cholinergic signaling was not adequately explored.</p>
</disp-quote>
<p>We plan to perform additional rescue experiments using heterologous promoters to drive gar-3 expression in specific tissues (e.g. cholinergic neurons, muscle). These experiments will help clarify the sufficiency of unc-17 expression in specific cell types for rescue. However, we point out that cell-specific unc-17 knockdown by RNAi using the unc-17b promoter (expression largely restricted to ventral cord ACh motor neurons) increases sensitivity to PQ in our long-term survival assays. Combined with our analysis of unc-17(e113) mutants, we believe our data offer robust support of a requirement for unc-17 expression in cholinergic motor neurons.</p>
<disp-quote content-type="editor-comment">
<p>(2) Pan-neuronal silencing experiments were not connected to ACh/GAR-3 signaling.</p>
</disp-quote>
<p>We will expand our discussion to relate the pan-neuronal silencing results to our analysis of ACh signaling. We used the pan-neuronal silencing to motivate further analysis of various neurotransmitter systems. We note that our studies implicate both glutamatergic and cholinergic systems in protective responses to oxidative stress. The effects of silencing on survival during long-term PQ exposure may therefore be derived solely from cholinergic neurons, glutamatergic neurons, or a combination of both neuronal populations. We hope the reviewer will agree that distinguishing between these possibilities may be quite complicated and is not central to the main message of our paper. We therefore suggest this additional analysis lies outside the scope of this revision.</p>
<disp-quote content-type="editor-comment">
<p>(3) Inter-tissue signaling and transcriptional regulation by ACh were assumed but not directly shown.</p>
</disp-quote>
<p>We will generate GFP reporters for a subset of genes (including proteasomal genes) identified in our RNA-seq analysis or assess their expression by quantitative RT-PCR to validate cholinergic regulation. These experiments will help to identify target tissues and confirm transcriptional regulation by cholinergic signaling.</p>
<p>We appreciate the opportunity to revise our manuscript and believe that these additions will significantly strengthen the mechanistic insights and overall impact of our study. Please let us know if further clarification is needed.</p>
</body>
</sub-article>
</article>